Lyme disease, including avohilmo

AB1_LYME_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A69.2 Hospital discharge: ICD-10 — A69.2 Hospital discharge: ICD-9 — 1048A Cause of death: ICD-10 — A69.2 Cause of death: ICD-9 — 1048A 3 out of 7 registries used, show all original rules.	17844
4. Check minimum number of events None	17844
5. Include endpoints None	17844
6. Filter based on genotype QC (FinnGen only)	16339

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF12

NAME	AB1_LYME_WIDE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A692
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A692
HD_ICD_9	1048A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A692
COD_ICD_9	1048A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lyme disease, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Lyme disease

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16339	10273	6066
Unadjusted period prevalence (%)	3.33	3.65	2.78
Median age at first event (years)	63.43	62.44	65.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16930: Matched controls
169299

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S12

ICPC

Insect bite/sting

7.6

307.7

4378

7461

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.5

307.7

1079

2535

A69.2

ICD-10 Finland

Lyme disease

535645.6

307.7

16679

J01CA04

ATC

amoxicillin; systemic

4.0

307.7

15409

121388

M01.2*A69.2

ICD-10 Finland

Arthritis in Lyme disease

116.8

272.8

139

S29

ICPC

Skin symptom/complaint other

1.7

176.9

3783

24007

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

355.0

175.7

177

S73

ICPC

Pediculosis/skin infestation other

12.1

175.6

176

147

S72

ICPC

Scabies/other acariasis

4.9

162.0

360

745

J01AA02

ATC

doxycycline; systemic

1.6

147.4

13060

114133

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

131.4

3791

25717

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

124.7

3668

24952

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

1217.8

124.1

121

TAB00

NOMESCO Finland

Lumbar puncture

2.3

106.3

824

3645

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

93.9

3197

22285

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

93.8

2261

14540

S13

ICPC

Animal/human bite

2.4

90.1

663

2864

A98

ICPC

Health maint/preventive medicine

2.9

88.1

16596

159880

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

86.0

673

2986

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

84.2

1330

7601

M25.5

ICD-10 Finland

Pain in joint

1.4

84.1

5464

42954

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

83.9

2912

20325

SPAT1262

SPAT

Handing over of treatment supplies

0.5

83.8

1037

18528

103

Kela drug reimbursment

Diabetes, insulin-treated

0.6

82.5

2035

30349

1048A

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]

+∞

81.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

77.9

4851

37745

SPAT1152

SPAT

Removal of foreign body from under the skin

2.7

77.6

437

1664

Z2221

NOMESCO Finland

Medical doctor

1.4

73.2

4103

31285

S08

ICPC

Skin colour change

1.9

71.5

909

4842

S06

ICPC

Rash localized

1.9

71.4

926

4964

B88.0

ICD-10 Finland

Other acariasis

6.3

70.9

118

187

L57.0

ICD-10 Finland

Actinic keratosis

1.6

68.0

1554

9811

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

65.8

2020

28964

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

63.6

7890

67546

A10BA02

ATC

metformin; oral

0.7

61.0

2373

32571

N73

ICPC

Neurological infection other

19.2

58.8

205

Kela drug reimbursment

Chronic hypertension

0.7

56.5

1911

26997

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.7

56.2

1895

26786

SPAT1324

SPAT

Screening procedure

0.6

55.2

1283

19621

C03CA01

ATC

furosemide; systemic

0.7

54.4

2228

30397

T90

ICPC

Diabetes non-insulin dependent

0.7

49.8

2105

28624

D22

ICD-10 Finland

Melanocytic naevi

1.7

49.7

859

5022

R83

ICPC

Respiratory infection other

1.3

48.8

3804

30231

G51.0

ICD-10 Finland

Bell palsy

2.2

48.5

418

1930

M04AB01

ATC

probenecid; oral

10.4

48.1

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

47.4

3511

27678

M01AH05

ATC

etoricoxib; oral

1.3

46.4

10043

90613

WX725

NOMESCO Finland

Noninvasive ventilation

0.4

46.2

202

5369

L548, A692,

ICD-10 Finland

+∞

45.8

D19

ICPC

Teeth/gum symptom/complaint

1.3

45.5

4768

39390

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

45.0

3926

31644

A10AE04

ATC

insulin glargine; parenteral

0.5

44.8

485

9131

S21

ICPC

Skin texture symptom/complaint

1.4

44.4

2300

17115

M79.6

ICD-10 Finland

Pain in limb

1.3

43.8

6937

60193

Z71.8

ICD-10 Finland

Other specified counselling

1.3

42.8

5219

43862

Z01.7

ICD-10 Finland

Laboratory examination

1.4

42.7

2529

19226

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.7

42.4

2226

29312

WX720

NOMESCO Finland

Own respiration

0.4

41.8

164

4586

WW200, ,

SPAT

1.3

41.0

4610

38318

H02

ICPC

Hearing complaint

1.4

40.5

2091

15535

J01FA10

ATC

azithromycin; systemic

1.2

38.0

8875

79872

R06AX27

ATC

desloratadine; oral

1.3

37.8

4287

35602

D01AE16

ATC

amorolfine; topical

1.4

36.3

1603

11576

H02AB07

ATC

prednisone; oral

1.4

35.0

1833

13628

A23

ICPC

Risk factor NOS

1.4

34.8

1389

9842

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

0.7

34.8

1252

17649

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

34.8

5330

45726

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

34.5

720

4424

A10AC01

ATC

insulin (human); parenteral

0.5

34.5

294

6000

WX704

NOMESCO Finland

Intubation

0.6

34.4

488

8505

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

34.4

403

2087

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

0.6

34.1

638

10343

A97

ICPC

No disease

1.3

34.0

2925

23397

R01AD09

ATC

mometasone; nasal

1.2

34.0

6885

60778

GD1AA, ,

SPAT

1.3

33.6

2354

18300

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

33.2

1046

7072

A10AB05

ATC

insulin aspart; parenteral

0.5

33.1

373

6953

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

32.9

335

6445

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

32.6

3279

26749

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

32.5

922

13626

SPAT1254

SPAT

Administration of medicine

0.7

32.5

979

14289

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

32.2

691

10851

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

32.1

807

5189

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

30.9

1847

14010

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

0.5

30.6

253

5219

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

30.6

1525

11232

H10

ICD-10 Finland

Conjunctivitis

1.5

30.3

1013

6932

S82

ICPC

Naevus/mole

1.3

30.1

2043

15790

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.4

30.1

201

834

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

29.9

4189

48990

H93.1

ICD-10 Finland

Tinnitus

1.5

29.9

1009

6917

D01BA02

ATC

terbinafine; oral

1.3

29.8

3610

30058

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.7

29.8

1230

16959

SPAT1222

SPAT

Counselling/guidance promoting independent living

0.7

29.3

1032

14636

J01DB01

ATC

cefalexin; oral

1.2

29.3

13182

125022

R01AD08

ATC

fluticasone; nasal

1.2

29.2

4134

35010

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.6

29.2

704

10777

V18

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident

3.2

29.1

117

372

SPAT1263

SPAT

Sampling

0.8

28.9

4556

52680

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

28.8

684

4339

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

28.8

4039

34171

TPH07

NOMESCO Finland

Cathetrisation of artery

0.7

28.7

771

11532

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

28.6

1501

11147

A28

ICPC

Limited function/disability NOS

0.7

28.5

1273

17330

C01CA24

ATC

epinephrine; parenteral

1.5

28.4

842

5616

Z51.5

ICD-10 Finland

Palliative care

0.6

28.2

470

7851

EB1AA, ,

SPAT

1.5

28.0

904

6139

D06BB10

ATC

imiquimod; topical

1.6

27.7

700

4506

R05

ICD-10 Finland

Cough

1.3

27.7

3138

25901

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

27.6

1401

10343

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

27.4

3630

30485

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

27.3

1239

8973

I50.0

ICD-10 Finland

Congestive heart failure

0.5

26.9

244

4877

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.4

26.8

165

3796

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

26.5

471

7741

W86

ICD-10 Finland

Exposure to other specified electric current

3.4

26.4

287

OAB50, ,

SPAT

0.6

26.1

532

8460

130

Kela drug reimbursment

Malignant tumour

0.6

26.0

510

8186

HA1RA, ,

SPAT

1.6

25.8

667

4317

J05AB11

ATC

valaciclovir; oral

1.3

25.8

2059

16254

L17

ICPC

Foot/toe symptom/complaint

1.2

25.6

4543

39283

M01.2

ICD-10 Finland

Arthritis in Lyme disease

44.3

25.5

Z20.7

ICD-10 Finland

Contact with and exposure to pediculosis, acariasis and other infestations

4.8

25.4

120

X58

ICD-10 Finland

Exposure to other specified factors

1.3

25.3

2043

16147

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

25.2

6286

56075

B35.1

ICD-10 Finland

Tinea unguium

1.5

24.9

937

6559

R74

ICPC

Upper respiratory infection acute

1.2

24.9

4764

41469

R4110

NOMESCO Finland

Physiotherapy

1.2

24.8

3912

33413

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

24.7

1187

8679

M79.1

ICD-10 Finland

Myalgia

1.3

24.6

2105

16762

SPAT1097

SPAT

Recording of ECG

0.7

24.6

1096

14946

F29

ICPC

Eye symptom/complaint other

1.3

24.5

1512

11505

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

24.5

1725

13382

N02AA05

ATC

oxycodone; systemic

0.7

24.4

1458

19003

S18

ICPC

Laceration/cut

1.2

24.2

7033

63498

R51.80

ICD-10 Finland

Headache

1.3

24.1

2146

17176

N05AX08

ATC

risperidone; systemic

0.6

24.0

414

6863

A10BB12

ATC

glimepiride; oral

0.5

24.0

247

4739

A10BH01

ATC

sitagliptin; oral

0.6

24.0

600

9124

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

23.9

1368

10285

R52.9

ICD-10 Finland

Pain, unspecified

1.3

23.9

1463

11114

A06AD11

ATC

lactulose; oral

0.7

23.7

954

13240

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.6

23.7

389

6528

PH2AE, ,

SPAT

1.9

23.7

308

1654

G04CA01

ATC

alfuzosin; oral

1.4

23.6

1341

10070

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

23.5

4464

38782

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

23.3

596

3847

M01AE02

ATC

naproxen; oral, rectal

1.2

22.9

8436

77538

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

22.8

2800

23257

H81

ICPC

Excessive ear wax

1.3

22.8

2297

18657

J20

ICD-10 Finland

Acute bronchitis

1.3

22.7

1440

10998

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

22.6

7273

66088

UDC00

NOMESCO Finland

Ear microscopy

0.6

22.5

434

6996

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

22.4

3340

28313

L08

ICPC

Shoulder symptom/complaint

1.2

22.4

3356

28472

SDA03

NOMESCO Finland

Periodontal treatment

1.2

22.0

6145

55149

M03BX02

ATC

tizanidine; oral

1.2

21.7

9609

89444

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

3.9

21.5

159

N05AA02

ATC

levomepromazine; systemic

0.4

21.4

136

3089

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

0.6

21.4

540

8196

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

0.5

21.3

172

3573

L30

ICD-10 Finland

Other dermatitis

1.8

21.2

323

1822

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

21.0

1262

9560

R51

ICD-10 Finland

Headache

1.5

20.8

737

5099

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

20.8

1311

9999

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

20.8

2258

18487

F38

ICPC

Eye, Other laboratory test NEC

1.9

20.6

241

1250

TPH04

NOMESCO Finland

Cathetrisation of vein

0.8

20.6

2098

25594

SPAT1301

SPAT

No procedures

0.8

20.4

3138

36665

A10AE05

ATC

insulin detemir; parenteral

0.5

20.3

235

4346

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

20.3

1079

8017

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

20.1

1881

15123

K08.80

ICD-10 Finland

Toothache NOS

1.3

20.1

1232

9357

G63.0

ICD-10 Finland

Polyneuropathy in infectious and parasitic diseases classified elsewhere

28.9

19.6

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

19.4

1539

12113

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

19.3

328

5458

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

19.3

1194

9078

Z01.2

ICD-10 Finland

Dental examination

1.2

19.3

7051

64423

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

19.3

769

5441

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

19.2

604

4081

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

19.1

957

7041

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

19.1

443

2799

H01.0

ICD-10 Finland

Blepharitis

1.4

19.0

922

6749

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.8

18.9

289

1635

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

18.9

6893

62942

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

18.8

685

4767

R01AD58

ATC

fluticasone, combinations; nasal

1.2

18.8

3535

30579

EBA15

NOMESCO Finland

Extraction of multiple teeth

0.5

18.6

159

3235

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

18.6

1127

8546

EB1SA, ,

SPAT

1.5

18.5

669

4648

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

18.4

1318

10231

SPAT1304

SPAT

Counselling and guidance related to ageing

0.6

18.4

330

5415

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

18.3

792

5685

L01

ICPC

Neck symptom/complaint

1.2

18.3

2284

18966

L15

ICPC

Knee symptom/complaint

1.2

18.2

3661

31837

M54

ICD-10 Finland

Dorsalgia

1.3

18.2

1668

13368

SPAT1100

SPAT

Long-term monitoring of blood pressure

0.6

18.1

318

5242

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

17.9

379

5981

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

17.8

374

5909

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

17.7

N05AH03

ATC

olanzapine; systemic

0.6

17.7

353

5645

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

17.7

14550

141067

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

17.7

1369

17279

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.3

17.7

1447

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.9

17.4

230

1245

NG2AA

NOMESCO Finland

Patella X-ray examination

1.6

17.4

368

2275

TK800

NOMESCO Finland

Hemodialysis

0.3

17.3

1479

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

17.3

3256

28133

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

17.2

3894

34185

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

17.2

495

3286

H92.0

ICD-10 Finland

Otalgia

1.4

17.0

824

6032

M67.4

ICD-10 Finland

Ganglion

1.4

17.0

903

6711

-31

ICPC

Medical examin/health eval partial

0.6

16.9

375

5856

L03

ICPC

Low back symptom/complaint

1.2

16.9

4203

37172

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

16.9

347

5509

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

16.8

826

11118

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.8

16.7

246

1376

J18.9

ICD-10 Finland

Pneumonia, unspecified

0.8

16.5

2295

27164

SPAT1193

SPAT

Pap smear

0.7

16.5

602

8513

A04AA02

ATC

granisetron; systemic, transdermal

0.7

16.4

419

6346

L13

ICPC

Hip symptom/complaint

1.2

16.3

2716

23197

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.5

16.1

175

3295

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

16.1

5216

47051

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

16.0

574

3985

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

15.9

4654

41653

A10BB01

ATC

glibenclamide; oral

0.4

15.8

1767

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

15.8

3620

31776

SPAT1148

SPAT

Treatment of chronic ulcer or burn

0.8

15.8

966

12589

A10BK03

ATC

empagliflozin; oral

0.7

15.8

802

10738

L53.8

ICD-10 Finland

Other specified erythematous conditions

3.2

15.8

191

N17.9

ICD-10 Finland

Acute renal failure, unspecified

0.5

15.8

165

3140

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.1

15.7

152

739

SPAT1229

SPAT

Assessment of need for aid

0.7

15.7

438

6511

R42

ICD-10 Finland

Dizziness and giddiness

1.2

15.6

3067

26568

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

15.6

1157

9021

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

15.6

565

3928

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.6

15.6

229

3952

R00.2

ICD-10 Finland

Palpitations

1.3

15.6

1060

8169

ZX080

NOMESCO Finland

Image guided radiotherapy

0.3

15.5

1604

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

0.5

15.5

151

2941

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

15.5

767

5633

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

160.2

15.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

15.5

1516

12243

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

0.8

15.5

1422

17595

CS494

NOMESCO Finland

Other visual field testing

1.6

15.4

316

1940

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.6

15.4

331

5198

OAB95, ,

SPAT

1.3

15.3

989

7566

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.3

2682

23003

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

15.2

4233

37711

M75

ICD-10 Finland

Shoulder lesions

1.4

15.2

567

3967

NH3AA, ,

SPAT

1.4

15.1

719

5246

G44.2

ICD-10 Finland

Tension-type headache

1.2

15.1

1827

15104

SPAT1245

SPAT

Provision of support and information to patient’s family members

0.5

15.0

128

2601

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.3

14.9

1312

N18.8

ICD-10 Finland

Other chronic renal failure

0.3

14.9

1494

HMAK, ,

NOMESCO Finland

0.8

14.8

912

11879

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

12.4

14.8

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

1.9

14.7

173

902

NG1BG, ,

SPAT

1.5

14.7

498

3419

OAA67, ,

SPAT

1.2

14.7

2216

18735

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

14.6

255

4206

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

0.3

14.5

1432

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.7

14.5

237

1369

J01

ICD-10 Finland

Acute sinusitis

1.4

14.5

718

5276

H02AB02

ATC

dexamethasone; systemic

0.8

14.5

972

12511

R06AX22

ATC

ebastine; oral

1.2

14.4

2303

19568

WX002

NOMESCO Finland

Sedation and analgesia

1.2

14.4

2445

20892

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.3

14.4

1425

SPAT1360

SPAT

Extensive global examination

1.4

14.4

804

6020

A10BJ06

ATC

semaglutide; parenteral

0.6

14.3

335

5167

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.4

14.3

573

4060

A10AA02, ,

ATC

0.4

14.2

2090

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

14.2

1258

10038

D01

ICPC

Abdominal pain/cramps general

1.2

14.1

1629

13399

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

14.1

140

2704

A10BH05

ATC

linagliptin; oral

0.6

14.0

245

4042

J01MA01

ATC

ofloxacin; systemic

1.3

13.9

904

6920

N17

ICPC

Vertigo/dizziness

1.2

13.9

1636

13479

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.6

13.9

309

4817

F45.8

ICD-10 Finland

Other somatoform disorders

1.3

13.9

825

6236

WX723

NOMESCO Finland

CPAP therapy

0.6

13.9

252

4116

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

13.8

373

5583

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

13.8

187

3296

SPAT1377

SPAT

Polysomnography

0.5

13.8

144

2738

M01AB05

ATC

diclofenac; systemic, rectal

1.1

13.8

9976

94559

N30

ICD-10 Finland

Cystitis

1.3

13.8

1051

8227

A02BC04

ATC

rabeprazole; oral

1.3

13.6

1135

8983

G04CB01

ATC

finasteride; oral

1.3

13.6

970

7523

C03DA01

ATC

spironolactone; oral

0.8

13.6

916

11784

R21

ICPC

Throat symptom/complaint

1.2

13.5

2784

24185

H60

ICD-10 Finland

Otitis externa

1.4

13.5

656

4807

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

13.4

925

11869

SPAT1395

SPAT

Health check-up of persons outside student and working life

0.4

13.4

1878

A10AB01

ATC

insulin (human); parenteral

0.5

13.4

123

2435

WX110, ,

SPAT

1.4

13.4

699

5183

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

13.3

775

10178

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

13.3

2650

22951

L12

ICPC

Hand/finger symptom/complaint

1.2

13.3

2365

20284

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

13.3

1455

L90.4

ICD-10 Finland

Acrodermatitis chronica atrophicans

11.4

13.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

13.2

4184

37560

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.4

13.2

1796

B01AB10

ATC

tinzaparin; parenteral

0.8

13.2

941

12015

HARJA, ,

NOMESCO Finland

3.1

13.1

171

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

0.6

13.1

227

3749

HA1AE, ,

SPAT

1.5

13.1

416

2823

K30

ICD-10 Finland

Functional dyspepsia

1.2

13.0

1513

12453

I50.1

ICD-10 Finland

Left ventricular failure

0.6

13.0

184

3199

C09AA05

ATC

ramipril; oral

0.8

12.9

2278

26444

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

12.9

694

5169

R35

ICD-10 Finland

Polyuria

1.3

12.8

799

6084

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.2

12.8

1877

15813

R06AE07

ATC

cetirizine; oral

1.1

12.8

6343

58633

J02AC02

ATC

itraconazole; systemic

1.2

12.8

2325

19981

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.3

12.7

1218

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

12.7

431

2962

R03BA02

ATC

budesonide; inhalant

1.2

12.7

2319

19930

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

12.7

7777

82785

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.9

12.7

4708

51687

N05AD01

ATC

haloperidol; systemic

0.5

12.7

2002

Z00.0

ICD-10 Finland

General medical examination

1.2

12.6

2515

21776

M15

ICD-10 Finland

Polyarthrosis

1.4

12.6

628

4621

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

12.6

1763

14785

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

12.5

772

5868

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.8

12.5

177

982

EBA00

NOMESCO Finland

Extraction of tooth

0.9

12.5

4192

46346

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

12.5

1182

14593

A49.9

ICD-10 Finland

Bacterial infection, unspecified

0.8

12.4

824

10627

A06AC51

ATC

ispaghula, combinations; oral

1.4

12.4

573

4167

P72

ICPC

Schizophrenia

0.4

12.3

1302

H61.2

ICD-10 Finland

Impacted cerumen

1.3

12.3

835

6438

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

12.2

2475

21465

N05AF03

ATC

chlorprothixene; systemic

0.5

12.2

1958

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.8

12.0

1052

13106

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

12.0

1681

14095

M23

ICD-10 Finland

Internal derangement of knee

1.6

12.0

304

1967

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.6

12.0

307

1992

A02BC05

ATC

esomeprazole; systemic

1.1

12.0

5767

53148

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

11.9

1183

9561

S04

ICPC

Lump/swelling localized

1.2

11.9

1426

11770

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.5

11.9

411

2837

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

11.9

7626

71471

T36

ICD-10 Finland

Poisoning by systemic antibiotics

0.6

11.8

213

3482

J37.0

ICD-10 Finland

Chronic laryngitis

1.5

11.8

395

2709

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.6

11.8

255

1589

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.2

11.8

1320

10813

R07.3

ICD-10 Finland

Other chest pain

1.2

11.8

1306

10690

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

11.8

1394

16804

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

0.5

11.7

1810

A10AE06

ATC

insulin degludec; parenteral

0.6

11.7

172

2962

H29

ICPC

Ear symptom/complaint other

1.2

11.7

1582

13219

XQ855

NOMESCO Finland

Skin temperature measurement

2.8

11.7

194

R01AD12

ATC

fluticasone furoate; nasal

1.1

11.6

4371

39636

MAX99

NOMESCO Finland

Assistance to normal delivery

1.3

11.6

664

4992

Z24.1

ICD-10 Finland

Need for immunization against arthropod-borne viral encephalitis

2.4

11.6

316

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

11.6

2337

26848

J05AB01

ATC

aciclovir; systemic

1.2

11.6

2895

25513

M77.4

ICD-10 Finland

Metatarsalgia

1.3

11.6

781

6015

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.2

11.6

1379

11375

XF402

NOMESCO Finland

ECG with work load test

1.2

11.6

1231

10031

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

0.2

11.5

495

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

11.5

968

7672

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.2

11.5

1266

10353

A10BD07

ATC

metformin and sitagliptin; systemic

0.6

11.5

219

3531

A84.8

ICD-10 Finland

Other tick-borne viral encephalitis

5.7

11.5

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.6

11.4

172

2942

H22.0*A69.2

ICD-10 Finland

Iridocyclitis in Lyme disease

120.1

11.4

NE1AA, ,

SPAT

1.6

11.4

229

1402

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.6

11.4

211

3426

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.5

11.4

109

2126

OAB43, ,

SPAT

1.1

11.4

4015

36252

A12BA01

ATC

potassium chloride; oral

0.5

11.4

129

2387

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

11.4

6268

58177

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

11.4

113

2177

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.2

11.4

1405

11634

A06AC01

ATC

ispaghula (psylla seeds); oral

1.1

11.3

3538

31676

SPAT1139

SPAT

Nutrition survey

0.5

11.3

139

2514

H02AB04

ATC

methylprednisolone; systemic

1.2

11.3

1809

15357

C10AA01

ATC

simvastatin; oral

0.9

11.3

4403

48278

XF640, ,

NOMESCO Finland

1.6

11.3

272

1741

LX2A3, ,

SPAT

0.5

11.3

129

2381

J01MA06

ATC

norfloxacin; oral

1.2

11.3

1554

13008

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

0.6

11.3

263

4050

A41.9

ICD-10 Finland

Sepsis, unspecified

0.6

11.2

141

2532

J45

ICD-10 Finland

Asthma

1.2

11.2

1335

11015

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.2

11.1

771

N05AH02

ATC

clozapine; systemic

0.4

11.1

1193

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

2.6

11.1

234

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

11.0

3558

31923

SPAT1079

SPAT

Echocardiography

0.2

11.0

816

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

11.0

1107

8965

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

11.0

2940

26031

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

11.0

848

6651

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.2

10.9

1452

12110

M01AX05

ATC

glucosamine; oral

1.2

10.9

2328

20256

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

10.9

2858

25268

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.4

10.8

1592

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

10.8

897

7099

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

10.8

1053

8495

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.4

10.8

437

3108

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

1.5

10.7

328

2211

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

10.7

748

5787

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.6

10.7

214

3409

D23

ICD-10 Finland

Other benign neoplasms of skin

1.5

10.7

279

1819

OAB47, ,

SPAT

0.7

10.6

314

4610

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

10.6

488

6634

-1, ,

NOMESCO Finland

0.9

10.6

3655

40426

N05AC02

ATC

thioridazine; oral

0.4

10.6

1298

ZY010, ,

SPAT

1.7

10.6

179

1049

N05BA06

ATC

lorazepam; systemic, sublingual

0.7

10.5

275

4136

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.4

10.5

375

2606

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

10.5

1604

13554

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

10.5

6144

57138

M19

ICD-10 Finland

Other arthrosis

1.5

10.5

268

1740

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

10.5

1727

20191

C09AA02

ATC

enalapril; systemic

0.8

10.5

1617

19014

R03BC03

ATC

nedocromil; inhalant

1.3

10.5

811

6364

S59

ICPC

Skin, Other therap proced/minor surg NEC

1.6

10.5

255

1638

H02AB06

ATC

prednisolone; systemic

1.1

10.4

6745

63071

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

0.2

10.4

445

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

10.4

1286

10646

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

1.8

10.4

140

767

K03.66

ICD-10 Finland

Tooth plaque

1.3

10.4

959

7690

J01AA04

ATC

lymecycline; systemic

1.2

10.4

1587

13417

H91.1

ICD-10 Finland

Presbycusis

1.3

10.3

635

4829

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

0.2

10.3

480

SPAT1279

SPAT

Preparation of immediate hospitalisation

0.2

10.3

461

NG1AA, ,

SPAT

1.2

10.3

1037

8399

TUPEI, ,

NOMESCO Finland

1.4

10.3

409

2901

K05.31

ICD-10 Finland

Periodontitis pronounced

0.8

10.2

965

11921

QBE99, ,

SPAT

2.0

10.2

113

581

B35.3

ICD-10 Finland

Tinea pedis

1.3

10.2

555

4147

ZXH09, ,

SPAT

1.5

10.1

265

1731

L29

ICPC

Musculoskeletal sympt/complt other

1.2

10.1

1131

9269

A11

ICPC

Chest pain NOS

1.2

10.1

1062

8645

K59.0

ICD-10 Finland

Constipation

1.3

10.0

634

4840

R23

ICD-10 Finland

Other skin changes

1.8

10.0

148

834

QX3HE, ,

SPAT

1.5

10.0

283

1878

WX402

NOMESCO Finland

General anaesthesia

0.9

10.0

2445

27703

A10AB04

ATC

insulin lispro; parenteral

0.6

10.0

130

2307

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.6

9.9

183

2971

SPAT1216

SPAT

Assessment of functional ability

0.8

9.9

1258

15069

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

9.9

384

2713

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.6

9.9

131

2312

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

9.8

856

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

9.8

1038

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

9.8

1255

D07AD01

ATC

clobetasol; topical

1.2

9.8

2230

19490

A11CC03

ATC

alfacalcidol; systemic

0.5

9.8

1628

SPAT1131

SPAT

Colonoscopy

0.6

9.8

144

2472

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

0.5

9.8

1476

K58

ICD-10 Finland

Irritable bowel syndrome

1.5

9.8

307

2084

Z37.0

ICD-10 Finland

Single live birth

1.3

9.7

722

5634

N04AA02

ATC

biperiden; systemic

0.4

9.7

1304

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.8

9.7

679

8691

J02AC01

ATC

fluconazole; systemic

1.1

9.7

5603

52016

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.4

9.7

369

2599

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.0

9.7

104

530

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

9.6

452

3299

R52.2

ICD-10 Finland

Other chronic pain

1.4

9.6

440

3198

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.6

503

3736

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

0.6

9.6

184

2957

A12AA04

ATC

calcium carbonate; oral

0.3

9.6

965

B01AF01

ATC

rivaroxaban; oral

1.2

9.6

1531

12994

SFB40

NOMESCO Finland

Filling of four surfaces reproduced outside mouth

2.1

9.6

417

R53

ICD-10 Finland

Malaise and fatigue

1.1

9.6

3238

29111

L50

ICD-10 Finland

Urticaria

1.6

9.6

201

1248

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

0.7

9.5

476

6387

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

9.5

659

5099

H36.01

ICD-10 Finland

Diabetic maculopathy

0.3

9.5

807

R053, ,

ICD-10 Finland

1.4

9.5

421

3045

QAE99, ,

SPAT

1.9

9.5

122

660

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

9.5

1430

N05AB03

ATC

perphenazine; systemic, rectal

0.6

9.4

165

2709

L19

ICPC

Muscle symptom/complaint NOS

1.4

9.4

341

2380

C09BA02

ATC

enalapril and diuretics; systemic

0.7

9.4

513

6793

S01

ICPC

Pain/tenderness of skin

1.3

9.4

552

4173

QCE99, ,

SPAT

2.8

9.4

161

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

1.7

9.4

178

1077

H58.8*A69.2

ICD-10 Finland

Ophthalmopathy in Lyme disease

+∞

9.4

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

9.4

403

2900

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

9.4

1601

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

0.4

9.3

1100

SPAT1059

SPAT

Spirometry at the office

0.7

9.3

302

4352

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

9.3

699

5465

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.6

9.3

116

2081

AN1

Coronary angiography

0.8

9.3

721

9110

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.1

9.3

6640

62304

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.3

9.3

624

4809

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.8

9.2

135

760

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

9.2

614

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

9.2

1096

13212

D06BB03

ATC

aciclovir; topical

1.3

9.2

532

4014

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

9.1

842

6752

DAX08

NOMESCO Finland

Fitting of hearing aid

1.3

9.1

614

4731

S83

ICD-10 Finland

Dislocation, sprain and strain of joints and ligaments of knee

1.5

9.1

242

1586

A91

ICPC

Abnormal result investigation NOS

1.3

9.1

629

4863

A10BK01

ATC

dapagliflozin; oral

0.8

9.1

615

7911

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

9.1

2363

20850

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.7

9.1

390

5356

Z25.1

ICD-10 Finland

Need for immunization against influenza

0.7

9.1

367

5090

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

9.1

440

3229

S97

ICPC

Chronic ulcer skin

0.7

9.1

405

5528

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

9.1

818

A26.0

ICD-10 Finland

Cutaneous erysipeloid

8.3

9.0

A10AA01, ,

ATC

0.5

9.0

1766

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

9.0

804

6422

C07AB07

ATC

bisoprolol; oral

0.9

9.0

5699

60997

U07

ICPC

Urine symptom/complaint other

1.2

9.0

1045

8601

L20

ICPC

Joint symptom/complaint NOS

1.4

9.0

468

3477

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.5

9.0

1774

A10AD05

ATC

insulin aspart; parenteral

0.3

9.0

842

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

8.9

1588

R12

ICD-10 Finland

Heartburn

1.2

8.9

1065

8786

DHB50

NOMESCO Finland

Turbinoplasty

1.5

8.9

282

1919

J01FA09

ATC

clarithromycin; systemic

1.1

8.9

4245

38948

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

8.9

2373

20982

U02

ICPC

Urinary frequency/urgency

1.2

8.9

1941

16908

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

8.9

752

5971

Z3226

NOMESCO Finland

Physiotherapist

1.2

8.9

2196

19312

C08CA01

ATC

amlodipine; oral

0.9

8.9

4342

47122

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

0.4

8.8

1214

H00.00

ICD-10 Finland

Hordeolum

1.3

8.8

540

4108

RF210, ,

NOMESCO Finland

0.6

8.8

120

2096

F20.10

ICD-10 Finland

Raise schizophrenia continuously

0.0

8.7

250

X59

ICD-10 Finland

Exposure to unspecified factor

1.1

8.7

2438

21622

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

8.7

1358

11495

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.3

8.7

785

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

8.7

2000

17487

R50.9

ICD-10 Finland

Fever, unspecified

1.2

8.7

1844

16025

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.2

8.7

1147

9561

T89

ICPC

Diabetes insulin dependent

0.7

8.7

211

3214

N05AX12

ATC

aripiprazole; systemic

0.6

8.6

205

3139

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1.7

8.6

141

820

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

8.6

1257

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1.5

8.6

227

1487

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.6

8.6

147

2423

SPAT1281

SPAT

Other administrative function

0.8

8.6

551

7128

N05BA02

ATC

chlordiazepoxide; systemic

0.5

8.5

1639

-1, ,

ICPC

0.6

8.5

197

3027

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.5

8.5

253

1703

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.0

8.4

472

N01

ICPC

Headache

1.2

8.4

1339

11355

C09CA06

ATC

candesartan; oral

1.1

8.4

3247

29406

WX872

NOMESCO Finland

Intensive care

0.7

8.4

302

4270

A84.9

ICD-10 Finland

Tick-borne viral encephalitis, unspecified

7.3

8.4

NA3BG, ,

SPAT

1.3

8.4

491

3711

N06DX01

ATC

memantine; oral

0.7

8.4

344

4757

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

0.7

8.4

230

3419

R01BA01

ATC

phenylpropanolamine; oral

1.3

8.4

600

4664

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.6

8.4

160

2570

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

0.4

8.4

901

C07AB02

ATC

metoprolol; systemic

0.9

8.3

1686

19394

S83.2

ICD-10 Finland

Tear of meniscus, current

1.2

8.3

822

6649

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

8.3

2054

18059

L89

ICD-10 Finland

Decubitus ulcer and pressure area

0.4

8.3

1141

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.6

8.3

187

2892

G04BD12

ATC

mirabegron; oral

1.2

8.3

1459

12487

SPAT1104

SPAT

Monitoring of emergency patient

0.7

8.3

425

5672

DM1QA, ,

SPAT

1.3

8.3

477

3600

M54.2

ICD-10 Finland

Cervicalgia

1.2

8.2

990

8176

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

0.7

8.2

241

3535

R03DC03

ATC

montelukast; oral

1.2

8.2

2130

18787

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.5

8.2

240

1608

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.5

8.2

265

1812

PE1AT

NOMESCO Finland

Femoral artery PTA

0.3

8.2

696

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.4

8.2

313

2209

C01AA05

ATC

digoxin; systemic

0.7

8.2

349

4792

F20

ICD-10 Finland

Schizophrenia

0.2

8.2

376

R06AE09

ATC

levocetirizine; oral

1.2

8.2

1778

15481

127

Kela drug reimbursment

Transplant complication

0.4

8.2

1106

S80.0

ICD-10 Finland

Contusion of knee

1.2

8.1

929

7631

AN2

Balloon angioplasty, including several vessels

0.6

8.1

1785

K80

ICPC

Cardiac arrhythmia NOS

1.2

8.1

1061

8835

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

0.8

8.1

799

9825

C01DA14

ATC

isosorbide mononitrate; oral

0.8

8.1

1003

12049

B01AA03

ATC

warfarin; systemic

0.8

8.1

1386

16168

M54.5

ICD-10 Finland

Low back pain

1.1

8.1

5155

47988

TNG10

NOMESCO Finland

Puncture of knee

1.7

8.1

135

791

L03

ICD-10 Finland

Cellulitis

1.8

8.1

123

702

HAMTE, ,

NOMESCO Finland

0.2

8.1

527

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

1.6

8.1

171

1066

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

8.0

137

2259

KE1BG

NOMESCO Finland

MRI of prostate

1.9

8.0

516

ZXC60

NOMESCO Finland

Application of heat

1.6

8.0

171

1068

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.2

8.0

890

7290

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.2

8.0

804

6514

R07.0

ICD-10 Finland

Pain in throat

1.2

8.0

869

7101

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.3

8.0

570

4430

EBA05, ,

SPAT

1.6

8.0

185

1178

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

0.7

8.0

194

2953

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

0.6

8.0

107

1878

L60.9

ICD-10 Finland

Nail disorder, unspecified

1.6

8.0

197

1273

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

8.0

492

6399

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

8.0

1859

16273

R1100, ,

SPAT

0.4

7.9

995

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

7.9

254

3663

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.4

7.9

336

2415

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.6

7.9

115

1976

H3601, E113,

ICD-10 Finland

0.3

7.9

790

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.3

7.9

454

3424

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

1.6

7.9

161

994

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

0.5

7.9

1284

UJD10, ,

SPAT

1.4

7.9

304

2149

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

0.8

7.9

1067

12708

B05DB

ATC

Hypertonic solutions

0.2

7.9

390

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.2

7.9

1028

8559

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

7.9

438

3288

B35

ICD-10 Finland

Dermatophytosis

1.9

7.9

491

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

0.6

7.9

119

2022

R03AC03

ATC

terbutaline; inhalant

1.2

7.9

1667

14483

WW500

NOMESCO Finland

Blood transfusion

0.7

7.9

218

3229

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.2

7.8

928

7652

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

0.6

7.8

170

2650

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.5

7.8

210

1383

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

0.6

7.8

100

1777

D82

ICPC

Teeth/gum disease

1.1

7.8

5228

48771

I49.1

ICD-10 Finland

Atrial premature depolarization

1.3

7.8

431

3233

S72.0

ICD-10 Finland

Fracture of neck of femur

0.6

7.8

143

2316

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

1.8

7.8

116

659

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.3

7.7

699

5596

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

0.7

7.7

242

3504

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

7.7

1526

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

1.9

7.7

466

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.5

7.7

1340

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

7.7

408

3040

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

7.7

4515

41828

N05AH04

ATC

quetiapine; oral

0.9

7.7

1661

19025

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.2

7.7

853

6986

TUPAE, ,

NOMESCO Finland

3.9

7.7

D07AC01

ATC

betamethasone; topical

1.1

7.6

4981

46394

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.3

7.6

623

4929

L50.0

ICD-10 Finland

Allergic urticaria

1.4

7.6

293

2072

F10.20

ICD-10 Finland

Alcohol dependence currently independent

0.5

7.6

1386

R05

ICPC

Cough

1.1

7.6

3419

31223

R03BB04

ATC

tiotropium bromide; inhalant

0.8

7.6

739

9097

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.3

7.6

505

3890

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.4

7.6

344

2502

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

7.6

118

1989

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

7.6

1150

9714

A03FA01

ATC

metoclopramide; systemic, rectal

0.9

7.6

2377

26521

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

1.6

7.6

148

906

NB2AT, ,

SPAT

1.9

7.5

520

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

0.4

7.5

813

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

0.2

7.5

567

160

Kela drug reimbursment

exenatide

0.5

7.5

1445

ND1AA, ,

SPAT

1.4

7.5

327

2364

WVA20, ,

SPAT

0.7

7.5

208

3079

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.1

7.5

2155

19145

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

7.5

713

5746

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.2

7.5

804

6566

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.4

7.5

339

2467

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.6

7.4

156

2448

R95

ICPC

Chron obstructive pulmonary disease

0.6

7.4

139

2239

DFF59

NOMESCO Finland

Other assessment of balance

1.8

7.4

113

646

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.4

7.4

332

2410

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

0.5

7.4

1268

R19.4

ICD-10 Finland

Change in bowel habit

1.4

7.4

336

2444

R01AD05

ATC

budesonide; nasal

1.2

7.4

857

7052

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

1.8

7.4

101

559

XQ800

NOMESCO Finland

Prick test

1.2

7.4

853

7017

WX730

NOMESCO Finland

Conventional respirator

0.4

7.4

1020

N02CC03

ATC

zolmitriptan; nasal, oral

1.3

7.4

606

4798

XX1XN

NOMESCO Finland

Other isotope examination

0.2

7.4

560

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

0.2

7.4

392

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.2

7.4

997

8334

NHQ40

NOMESCO Finland

Amputation of toe

0.4

7.4

920

OAB48, ,

SPAT

1.1

7.4

2002

17716

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.2

7.3

1144

9689

N02AA01

ATC

morphine; systemic, rectal

0.5

7.3

1072

WX290, ,

SPAT

1.4

7.3

373

2766

C02EA02, ,

ATC

0.6

7.3

159

2473

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.8

7.3

643

7999

F51.0

ICD-10 Finland

Nonorganic insomnia

1.1

7.3

2148

19111

U09

ICD-10 Finland

Post COVID-19 condition

1.8

7.3

101

562

M20.2

ICD-10 Finland

Hallux rigidus

1.4

7.3

358

2640

N05AF05

ATC

zuclopenthixol; systemic

0.3

7.3

603

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.2

7.3

831

6831

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

0.2

7.3

522

J01DC02

ATC

cefuroxime; systemic

1.3

7.3

607

4818

C07FB02

ATC

metoprolol and felodipine; systemic

0.6

7.2

115

1927

E03

ICD-10 Finland

Other hypothyroidism

1.2

7.2

720

5831

R01AD59

ATC

mometasone, combinations; nasal

1.2

7.2

768

6264

PD3AT

NOMESCO Finland

Pelvic artery PTA

0.2

7.2

331

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

7.2

940

KAY20, ,

NOMESCO Finland

1.6

7.2

137

833

EB4VA, ,

NOMESCO Finland

1.1

7.2

2282

20400

K40

ICD-10 Finland

Inguinal hernia

1.5

7.2

220

1491

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.4

7.2

323

2348

WX320

NOMESCO Finland

Spinalanesthesy

1.1

7.2

3178

28991

XA402

NOMESCO Finland

ENMG

1.4

7.2

272

1921

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

7.1

628

E87.5

ICD-10 Finland

Hyperkalaemia

0.5

7.1

1129

K05.1

ICD-10 Finland

Chronic gingivitis

1.2

7.1

796

6527

UJH02

NOMESCO Finland

Anoscopy

1.3

7.1

455

3488

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

1.6

7.1

152

953

177

Kela drug reimbursment

Insulin glargine 300 U / ml

0.5

7.1

1352

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

7.1

646

5182

R56.8

ICD-10 Finland

Other and unspecified convulsions

0.7

7.1

292

4025

WX702

NOMESCO Finland

Supraglottic ventilation device

0.8

7.1

423

5519

NH1BG, ,

SPAT

1.5

7.1

186

1222

R49.03

ICD-10 Finland

Atrophic dysphonia

1.7

7.0

124

739

E66.8

ICD-10 Finland

Other obesity

0.8

7.0

413

5404

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

0.2

7.0

360

XQ855, ,

SPAT

0.4

7.0

873

ND2AA, ,

SPAT

1.3

7.0

642

5151

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

1.5

7.0

180

1176

H3603, E103,

ICD-10 Finland

0.3

7.0

590

KAY40, ,

NOMESCO Finland

1.5

7.0

206

1386

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

0.6

7.0

1528

H40.1

ICD-10 Finland

Primary open-angle glaucoma

2.5

7.0

158

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

1.7

7.0

132

802

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

0.5

7.0

1253

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

0.4

7.0

798

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.3

7.0

444

3404

WZC30

NOMESCO Finland

Teaching

0.9

7.0

1692

19212

E66.9

ICD-10 Finland

Obesity, unspecified

0.7

7.0

211

3068

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

0.2

6.9

319

E86

ICD-10 Finland

Volume depletion

0.6

6.9

1525

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

0.2

6.9

380

N05CD07

ATC

temazepam; oral

0.8

6.9

849

10202

N07BA03

ATC

varenicline; oral

0.7

6.9

327

4413

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.3

6.9

412

3129

SPD00

NOMESCO Finland

Mucosa borne complete denture

0.3

6.9

676

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

6.9

1304

11230

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

0.3

6.9

599

SPAT1240

SPAT

Therapeutic discussion

0.8

6.9

827

9956

Z04

ICD-10 Finland

Examination and observation for other reasons

1.6

6.9

169

1094

OAB72

NOMESCO Finland

Weight control and weight loss guidance

0.3

6.9

614

XFE00

NOMESCO Finland

Epicardial ultrasonography

0.5

6.8

1429

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.2

6.8

1024

8642

G03DC05

ATC

[U] tibolone

1.3

6.8

489

3808

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

6.8

337

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

0.6

6.8

125

2020

XF610

NOMESCO Finland

Measurement of pulsvariation

3.3

6.8

J33.8

ICD-10 Finland

Other polyp of sinus

1.5

6.8

218

1492

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.2

6.8

805

6643

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.4

6.8

715

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

1.6

6.7

149

941

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

6.7

423

3236

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

0.2

6.7

464

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

6.7

545

L29

ICD-10 Finland

Pruritus

1.6

6.7

164

1060

N05AA01

ATC

chlorpromazine; systemic, rectal

0.4

6.7

799

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.3

6.7

417

3186

WYA20

NOMESCO Finland

Home visit

0.5

6.7

995

E0000UV, ,

ATC

1.1

6.7

5795

54620

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

6.7

935

7840

N76.0

ICD-10 Finland

Acute vaginitis

1.2

6.7

674

5467

F16

ICPC

Eyelid symptom/complaint

1.3

6.7

607

4866

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.3

6.7

352

2625

Z94.0

ICD-10 Finland

Kidney transplant status

0.4

6.7

725

137

Kela drug reimbursment

Uraemia requiring dialysis

0.3

6.7

510

SPAT1255

SPAT

Intravenous administration of medicine

0.8

6.7

467

5968

M25.9

ICD-10 Finland

Joint disorder, unspecified

1.7

6.7

114

675

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

0.2

6.7

368

J02

ICD-10 Finland

Acute pharyngitis

1.3

6.7

365

2739

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.4

6.7

227

1573

T82

ICPC

Obesity

0.7

6.6

295

4018

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

6.6

1293

11160

M19.8

ICD-10 Finland

Other specified arthrosis

1.3

6.6

468

3639

G50.1

ICD-10 Finland

Atypical facial pain

1.5

6.6

198

1337

ITSEH, ,

NOMESCO Finland

0.2

6.6

290

XX2RW, ,

NOMESCO Finland

0.5

6.6

1071

H57.1

ICD-10 Finland

Ocular pain

1.3

6.6

444

3429

R52.0

ICD-10 Finland

Acute pain

1.3

6.6

351

2622

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.6

3211

34956

V03AE01

ATC

polystyrene sulfonate; oral

0.4

6.6

735

N07BB01

ATC

disulfiram; oral

0.7

6.6

250

3493

K59.1

ICD-10 Finland

Functional diarrhoea

1.2

6.6

642

5189

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.6

1668

14686

E66.00

ICD-10 Finland

Metabolic syndrome

0.8

6.6

413

5352

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

6.6

1292

11160

DM1AI, ,

SPAT

1.8

6.6

471

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.1

6.6

2175

19494

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

6.6

1319

H25

ICD-10 Finland

Senile cataract

1.7

6.5

113

671

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

0.5

6.5

1279

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

6.5

882

7374

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.3

6.5

433

3339

EB1CA, ,

SPAT

1.8

6.5

545

H81.3

ICD-10 Finland

Other peripheral vertigo

1.4

6.5

307

2252

N64.4

ICD-10 Finland

Mastodynia

1.3

6.5

378

2862

H3603, E113,

ICD-10 Finland

0.2

6.5

453

H00.1

ICD-10 Finland

Chalazion

1.3

6.5

435

3359

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

0.5

6.5

1289

D06BX02

ATC

ingenol mebutate; topical

1.7

6.5

114

680

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

1.7

6.5

106

620

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.4

6.5

240

1689

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

0.5

6.5

1089

U01

ICPC

Dysuria/painful urination

1.2

6.5

945

7961

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

0.4

6.5

756

L02

ICPC

Back symptom/complaint

1.2

6.4

1281

11077

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

0.4

6.4

697

J01FA06

ATC

roxithromycin; oral

1.1

6.4

5288

49709

NB1DG, ,

SPAT

1.6

6.4

128

790

Z50.0

ICD-10 Finland

Cardiac rehabilitation

0.3

6.4

575

A10AD01

ATC

insulin (human); parenteral

0.4

6.4

866

NH1AA, ,

SPAT

1.3

6.4

357

2688

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.3

6.4

369

2792

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

1.5

6.4

157

1018

SFA20

NOMESCO Finland

Two-surface restoration

1.1

6.4

8673

83274

TK810

NOMESCO Finland

Hemofiltration

0.2

6.4

361

RTGOM, ,

NOMESCO Finland

3.0

6.4

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

0.8

6.4

451

5752

SPAT1251

SPAT

Organisation of medication

0.7

6.3

150

2288

H25.8

ICD-10 Finland

Other senile cataract

1.2

6.3

1107

9471

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.3

6.3

534

4246

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.6

6.3

1472

C09CA01

ATC

losartan; oral

0.9

6.3

2768

30316

P70

ICPC

Dementia

0.5

6.3

1225

G01AA10

ATC

clindamycin; vaginal

1.1

6.3

1781

15797

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.3

6.3

558

4463

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

0.3

6.3

524

ULC02

NOMESCO Finland

Hysteroscopy

1.3

6.3

565

4528

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.4

6.3

212

1468

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

0.5

6.2

1286

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.3

6.2

398

3054

R41.3

ICD-10 Finland

Other amnesia

1.4

6.2

286

2089

S15

ICPC

Foreign body in skin

1.2

6.2

757

6265

I84

ICD-10 Finland

Hemorrhoids

1.4

6.2

275

1996

J01MA02

ATC

ciprofloxacin; systemic

1.1

6.2

5086

47781

L71

ICD-10 Finland

Rosacea

1.4

6.2

298

2192

C50

ICD-10 Finland

Malignant neoplasm of breast

1.4

6.2

282

2056

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.5

6.2

1258

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.2

6.2

794

6605

XQ899

NOMESCO Finland

Other assessment of skin

2.1

6.2

257

C02AC05

ATC

moxonidine; oral

0.7

6.2

277

3764

A10BJ02

ATC

liraglutide; parenteral

0.7

6.2

171

2526

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

0.7

6.2

145

2214

R4120

NOMESCO Finland

Occupational therapy

1.2

6.2

735

6072

Z10.0

ICD-10 Finland

Occupational health examination

1.2

6.2

1030

8782

I25.2

ICD-10 Finland

Old myocardial infarction

0.7

6.2

307

4105

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.5

6.1

205

1416

SPAT1053

SPAT

Memory test

0.8

6.1

1038

12119

ZXD05

NOMESCO Finland

Urgent procedure

0.9

6.1

3140

34107

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

0.9

6.1

1279

14685

C10AA07

ATC

rosuvastatin; oral

1.1

6.1

4721

44237

Z51.6

ICD-10 Finland

Desensitization to allergens

1.7

6.1

109

654

B35.4

ICD-10 Finland

Tinea corporis

1.5

6.1

151

981

SPAT1252

SPAT

Overall medication plan or its review

0.8

6.1

441

5609

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

6.1

1489

13077

EBA30

NOMESCO Finland

Extraction of root of tooth

0.8

6.1

410

5258

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

0.3

6.1

558

R51.81

ICD-10 Finland

Facial pain NOS

1.4

6.0

260

1880

WZC00, ,

SPAT

0.9

6.0

1539

17422

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.9

6.0

3121

33888

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

0.7

6.0

307

4092

H53

ICD-10 Finland

Visual disturbances

1.7

6.0

101

596

Z3232

NOMESCO Finland

Midwife

1.2

6.0

629

5127

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

0.6

6.0

125

1959

ZX120, ,

SPAT

0.5

6.0

1008

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

1.6

6.0

120

741

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

0.2

6.0

271

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.2

6.0

1108

9524

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3956

9728

5.00

307.65

1.7

1.2

62.66

43.68

au/ml

8.34

787

410

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

412

464

9.08

307.65

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4404

10451

5.34

307.65

3.2

2.3

29.14

18.76

au/ml

14.14

970

968

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

418

543

7.87

301.20

1.1

994.09

309.68

ng/l

1.16

125

139

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

406

627

6.61

249.95

1.1

0.11

0.99

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3095

18547

1.82

176.04

5.1

5.0

32.93

32.37

1.87

1799

12645

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

546

1596

3.50

154.21

1.1

31.99

4.70

au/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

356

6.39

135.20

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

480

1421

3.45

132.83

1.1

—

(40761536) Microorganisms panel - Urine sediment

451

12757

0.34

121.66

4.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

855

4028

2.18

94.57

1.2

1.4

568.83

531.94

mg/l

1.27

831

3849

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

786

15772

0.47

91.39

2.5

3.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

569

12872

0.42

91.09

2.7

3.9

1.23

mmol/l

1.11

506

11136

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

15413

144684

1.73

87.53

13.6

15.7

82.67

81.87

ml/min/173m2

6.58

14086

134148

(3019225) pH of Specimen

2242

14749

1.60

84.02

3.6

4.3

7.36

0.55

1365

10702

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

748

3563

2.15

80.27

1.2

1.3

3.51

3.76

mmol/l

12.28

705

3378

(3000963) Hemoglobin [Mass/volume] in Blood

16723

162221

3.52

79.01

22.1

24.8

136.42

135.28

g/l

26.23

16546

160800

(3007461) Platelets [#/volume] in Blood

16715

162132

3.44

78.30

22.0

24.7

248.51

254.19

e9/l

28.92

16353

159114

(3026361) Erythrocytes [#/volume] in Blood

16718

162192

3.46

78.01

21.9

24.6

4.52

4.49

e12/l

10.03

16265

158677

(3035941) MCH [Entitic mass]

16716

162173

3.43

77.77

21.9

24.6

30.39

30.31

9.05

16537

160727

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16716

162178

3.43

77.67

21.9

24.6

91.20

91.08

3.16

16535

160734

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16716

162186

3.43

77.50

22.3

25.1

41.02

40.87

0.19

16534

160685

(3010813) Leukocytes [#/volume] in Blood

16716

162212

3.41

76.96

22.0

24.7

6.36

6.69

e9/l

53.53

16303

158648

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

157

7.24

76.76

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16365

157783

2.11

67.36

12.2

12.6

25.68

26.36

u/l

5.77

15846

153773

(3017181) Myelocytes/Leukocytes in Blood

858

15024

0.55

63.29

4.3

4.5

0.84

0.95

0.53

285

4505

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

331

1225

2.74

62.18

1.2

53.65

39.89

mg/l

2.93

315

1020

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

308

1102

2.83

61.70

1.1

—

(3023410) Appearance of Cerebral spinal fluid

386

1567

2.50

60.11

1.3

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

320

1194

2.71

59.18

1.1

318.94

256.68

mg/l

4.01

306

1048

(3021440) Promyelocytes/Leukocytes in Blood

828

14385

0.55

59.14

4.4

4.6

0.09

0.12

0.64

258

3882

(3002179) Metamyelocytes/Leukocytes in Blood

830

14339

0.56

58.04

4.2

4.4

0.70

0.73

0.10

303

4294

(3025159) Blasts/Leukocytes in Blood

847

14542

0.56

57.92

4.6

4.8

0.05

0.36

4.58

248

3710

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15780

151107

1.65

57.32

6.0

5.9

2.79

2.74

mmol/l

11.93

14585

141690

(3047181) Lactate [Moles/volume] in Blood

132

4822

0.27

56.35

3.3

5.9

1.24

1.30

mmol/l

0.40

121

4263

(3010421) pH of Blood

156

5141

0.30

55.24

3.0

3.6

7.41

0.09

156

5082

(3041096) Erythrocytes [Presence] in Urine by Automated

3574

45190

0.73

55.11

2.7

3.4

0.94

0.24

estimate

0.72

678

14052

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15540

148456

1.57

54.68

5.3

5.1

1.53

1.48

mmol/l

49.95

14357

138930

(3029937) Albumin [Presence] in Urine by Test strip

3688

46338

0.74

54.33

3.7

4.2

0.00

estimate

4.59

824

16319

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16367

158595

1.96

53.99

18.2

20.9

74.02

75.82

umol/l

21.63

16134

157042

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4772

38735

1.32

53.80

2.2

2.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

302

7161

0.41

53.13

3.1

5.1

1.46

1.63

2.42

291

6782

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15599

149264

1.57

53.13

5.2

4.76

4.68

mmol/l

21.05

14482

140468

(3007930) Methemoglobin/Hemoglobin.total in Blood

258

6522

0.39

52.79

3.4

5.4

0.83

0.88

0.79

250

6163

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2451

32614

0.71

51.32

1.5

1.7

25656708.52

32752934.93

pmol/l

0.30

2019

27317

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

307

1229

2.53

49.30

1.2

1.3

1.91

2.14

mmol/l

3.85

279

1149

(3008152) Bicarbonate [Moles/volume] in Arterial blood

514

9740

0.51

48.58

6.6

7.2

24.69

24.59

mmol/l

0.34

505

9327

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3521

27686

1.34

48.52

2.9

3.0

0.83

1.23

e6/l

2.83

1790

14653

(3011397) Hemoglobin [Presence] in Urine by Test strip

4645

38166

1.30

46.39

3.5

3.8

0.29

0.32

—

358

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

234

849

2.78

45.76

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3177

24786

1.35

45.75

3.5

3.2

0.72

0.76

ug/l

1.38

2038

16186

(3033658) Prothrombin time (PT) actual/Normal

4877

40488

1.29

44.60

3.6

4.2

92.40

91.13

3.32

4774

39577

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12423

115352

1.29

43.86

4.7

4.5

10.06

11.99

mm/h

62.32

11564

108500

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14866

141661

1.41

43.78

4.4

1.22

1.30

mmol/l

40.99

13552

131353

(3035320) C reactive protein [Mass/volume] in Body fluid

289

1202

2.43

42.80

3.0

2.7

24.87

27.95

mg/l

0.76

207

870

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2342

17603

1.38

42.42

5.1

6.7

—

(3018572) Chloride [Moles/volume] in Blood

3322

0.24

42.41

3.9

7.0

104.99

105.09

mmol/l

0.10

2988

(3039000) Anion gap in Blood by calculation

3321

0.24

42.39

3.9

7.0

11.34

11.19

mmol/l

0.18

2986

(3027315) Oxygen [Partial pressure] in Blood

3317

0.25

41.29

3.4

3.9

8.83

8.69

kpa

0.36

3249

(3013290) Carbon dioxide [Partial pressure] in Blood

3294

0.25

40.81

3.4

3.9

5.04

5.00

kpa

0.21

3227

(3012501) Base excess in Blood by calculation

3292

0.25

40.77

3.4

3.9

1.94

2.47

mmol/l

1.95

2247

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

382

1826

2.12

40.58

1.8

2.1

20.67

25.81

mg/l

1.15

717

(40768443) Skin Pathology biopsy report

1124

7411

1.55

40.21

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14870

142104

1.38

39.46

5.9

6.4

37.85

39.17

mmol/mol

104.00

13671

133801

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

629

3607

1.77

38.82

1.3

1.5

256.05

2583.94

e6/l

1.51

456

2843

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

206

763

2.72

38.79

1.2

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15501

149346

1.45

37.94

14.0

16.2

22.39

23.67

mg/l

4.73

12305

123166

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3530

28642

1.29

37.32

1.4

1.3

11.65

11.75

u/ml

0.03

1166

11324

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5451

62987

0.80

37.21

3.3

3.9

2.22

0.45

estimate

0.79

685

14383

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2219

16873

1.36

36.96

2.0

3.36

3.47

ratio

3.82

1730

13013

(3014051) Protein [Presence] in Urine by Test strip

5281

45052

1.25

36.74

2.8

2.9

0.00

0.07

8.28

975

(3006462) Nitrate [Presence] in Urine

179

645

2.79

35.57

4.1

3.1

—

(1616796) Gas panel - Central venous blood

117

3559

0.32

35.43

3.1

3.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

609

3559

1.74

35.19

1.3

1.4

36.05

39.05

e6/l

0.10

419

2621

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7745

69084

1.22

34.82

2.2

2.1

101.01

97.18

pmol/l

8.65

3710

36537

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

696

4238

1.67

34.55

1.2

3.93

3.82

0.11

582

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3752

30978

1.27

34.03

1.4

1.3

34.26

33.28

iu/ml

0.11

1044

9505

(3037522) Nuclear Ab [Titer] in Serum

2928

23562

1.29

32.36

1.4

478.01

526.06

titre

0.78

624

5070

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14696

140975

1.32

31.56

5.7

5.6

1.89

1.90

mu/l

0.22

13400

131488

(4211845) Urine protein measurement

183

710

2.59

31.52

4.0

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3099

25223

1.28

31.19

3.0

3.1

2.30

2.87

e6/l

2.20

1358

12145

(3007164) IgA [Mass/volume] in Serum or Plasma

3891

32626

1.25

30.32

1.5

2.30

2.41

g/l

2.51

2110

20291

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1660

12449

1.37

29.78

1.7

3.49

mmol/l

0.04

1161

8543

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

186

4.21

29.69

1.2

1.3

78.51

50.99

6.09

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

747

4821

1.57

29.25

1.3

3.20

8.10

u/ml

5.59

719

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

768

2.46

29.11

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

747

4827

1.57

29.09

1.3

2.16

5.91

u/ml

2.00

473

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15013

144801

1.32

28.29

5.3

5.2

5.75

5.92

mmol/l

85.60

13672

134263

(3004616) Nuclear Ab [Presence] in Serum

391

2139

1.85

28.27

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

868

5843

1.51

28.06

1.8

1.7

—

(3035715) Granulocytes [#/volume] in Blood

107

3016

0.35

27.78

3.8

3.4

3.76

4.05

e9/l

1.05

107

3011

(3026782) Osmolality of Urine

2415

29817

0.78

27.26

2.5

3.0

549.35

526.54

mosm/kgh2o

5.55

1998

26217

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1573

1.97

27.10

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

782

5191

1.53

26.99

1.3

38.72

39.89

u/ml

0.03

284

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.43

26.86

1.1

1.2

7.33

26.05

1.79

(36660697) Celiac disease serology panel - Serum

1723

13203

1.34

26.71

1.2

—

(3018010) Neutrophils/Leukocytes in Blood

8224

74903

1.19

26.49

6.6

6.7

55.64

57.10

26.51

7699

71736

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

116

392

2.97

26.05

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

635

4085

1.58

25.22

1.2

1.3

1.16

4.23

u/ml

2.92

270

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

177

755

2.36

24.99

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

388

2.93

24.69

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

994

7051

1.44

24.57

1.7

1.8

8.32

7.21

iu/ml

0.42

201

1705

(3020682) Albumin/Creatinine [Ratio] in Urine

4639

52937

0.83

24.48

3.7

4.2

6.09

8.39

mg/mmol

1.51

2556

32426

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

324

1751

1.87

24.41

1.2

30.94

46.67

u/ml

0.36

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

110

382

2.89

23.57

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

648

4255

1.54

23.52

1.3

14.26

14.23

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

418

6872

0.60

23.48

2.5

3.5

25.27

25.28

mmol/l

0.02

413

6650

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1943

15436

1.29

23.03

2.3

2.6

37.36

49.55

u/l

1.34

1646

13113

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

449

2724

1.67

22.68

1.1

16.23

14.33

au/ml

0.16

103

662

(3048689) Calprotectin [Mass/mass] in Stool

2588

21340

1.25

22.51

2.3

2.4

110.43

133.24

ug/g

2.98

1975

17024

(3044640) Blood type and Crossmatch panel - Blood

5726

51036

1.18

22.38

2.2

2.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15659

152607

1.35

22.25

15.8

18.9

3.95

3.96

mmol/l

7.82

15278

149662

(3037467) Urinalysis macro (dipstick) panel - Urine

11193

105417

1.18

22.19

4.5

4.6

1.68

2.39

0.90

163

(3019550) Sodium [Moles/volume] in Serum or Plasma

15629

152289

1.34

22.08

15.6

18.8

139.93

139.71

mmol/l

25.32

15285

149585

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

255

1319

1.95

21.99

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1356

1.93

21.88

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7964

73019

1.17

21.85

2.4

2.5

79.27

1306.31

nmol/l

0.50

7009

66736

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

398

2367

1.70

21.69

1.2

2.25

12.82

u/ml

3.33

103

(3006315) Basophils [#/volume] in Blood

8798

81358

1.17

21.53

6.7

6.6

0.04

e9/l

1.63

7365

70103

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11153

105120

1.18

21.48

3.3

3.4

40.63

47.92

u/l

19.67

10423

99147

(3013650) Neutrophils [#/volume] in Blood by Automated count

9715

90553

1.17

21.47

9.1

10.2

3.72

4.09

e9/l

46.82

8204

78756

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

258

1354

1.92

21.33

1.2

—

(3013115) Eosinophils [#/volume] in Blood

9034

83765

1.17

21.21

6.8

0.19

e9/l

3.21

7724

73368

(3001604) Monocytes [#/volume] in Blood

8770

81139

1.17

21.15

6.7

6.6

0.55

0.58

e9/l

40.21

7348

69936

(3006504) Eosinophils/Leukocytes in Blood

8095

74452

1.17

21.00

6.8

2.92

2.85

2.29

7501

69986

(3000012) Reticulocyte production index

2213

0.34

20.92

2.2

2.1

0.94

0.92

0.14

1480

(40759836) Histone Ab [Presence] in Serum by Immunoblot

260

1377

1.90

20.92

1.2

—

(3019069) Monocytes/Leukocytes in Blood

8113

74649

1.17

20.88

6.9

8.84

8.79

0.87

7525

70234

(3022806) Fractional oxyhemoglobin in Capillary blood

1847

0.29

20.63

1.8

91.16

89.90

0.86

1821

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1406

1.88

20.57

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1450

18495

0.76

20.49

7.0

8.1

13.53

12.56

kpa

7.77

1414

17844

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

357

2.81

20.44

1.1

—

(3003396) Base excess in Arterial blood by calculation

1438

18349

0.76

20.37

7.0

8.0

0.47

0.94

mmol/l

6.01

1265

15275

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1452

18502

0.76

20.35

7.0

8.1

5.09

5.10

kpa

0.21

1414

17858

(3019977) pH of Arterial blood

1453

18502

0.77

20.25

7.0

8.1

7.43

7.42

2.77

575

10067

(3018333) Ribosomal P Ab [Presence] in Serum

243

1275

1.92

20.13

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1305

1.91

20.04

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

783

5521

1.44

19.99

2.6

2.5

0.74

0.81

g/l

0.23

682

4767

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

258

4614

0.55

19.90

1.4

1.7

—

(3022096) Basophils/Leukocytes in Blood

8074

74459

1.16

19.68

6.9

0.73

0.69

9.10

7478

69953

(3019198) Lymphocytes [#/volume] in Blood

8917

82859

1.16

19.61

6.6

1.93

e9/l

0.02

7650

73113

(3022145) Colonoscopy Study observation

2301

19010

1.24

19.42

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

875

11924

0.72

19.36

2.1

2.9

136.19

174.14

ng/l

4.68

793

10902

(3016502) Oxygen saturation in Arterial blood

1281

16481

0.76

19.22

7.4

8.4

95.89

95.69

0.46

1267

15930

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1191

15467

0.75

19.12

7.9

8.9

122.66

121.06

g/l

2.26

1183

15112

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

197

979

2.02

19.11

1.1

0.85

1.21

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2088

0.36

19.10

2.3

2.1

33.33

32.63

1.00

2073

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

660

4559

1.47

18.79

1.5

23.97

16.64

iu/ml

0.41

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

199

3.38

18.77

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

373

2282

1.65

18.32

1.1

3.69

2.44

0.48

373

(3002030) Lymphocytes/Leukocytes in Blood

8240

76348

1.15

18.25

6.7

6.8

29.53

28.05

30.45

7750

72525

(3022621) pH of Urine by Test strip

1571

12497

1.28

18.23

2.4

2.6

6.00

6.06

1.93

868

8351

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4697

41729

1.17

18.13

6.1

5.5

2.31

3.03

ug/l

3.12

4207

37997

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1511

11986

1.29

17.92

2.3

13.74

13.03

nmol/l

2.71

1350

10852

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

264

1479

1.80

17.84

1.2

79.30

78.93

u/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

1374

0.24

17.82

3.5

3.0

83.91

48.58

mg/l

0.23

985

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1729

21217

0.79

17.64

4.4

6.2

1.02

1.04

mmol/l

2.27

1571

19848

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

771

5553

1.41

17.50

1.6

1.7

3.14

4.38

mg/l

3.31

554

4145

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

608

4197

1.47

17.39

2.7

2.5

0.00

g/l

-0.00

564

3936

(1761482) Bacteria [#/volume] in Urine by Culture

179

3426

0.52

17.37

4.0

4.1

—

(3012516) Albumin [Mass/volume] in Urine

4669

52118

0.86

17.22

3.3

3.5

34.36

45.84

mg/l

1.80

2639

32620

(3032080) INR in Blood by Coagulation assay

6550

71261

0.87

16.92

12.8

13.9

1.22

inr

0.01

4924

59331

(3005988) Vibrio sp identified in Specimen by Organism specific culture

322

1938

1.67

16.88

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

283

1648

1.73

16.76

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3801

33369

1.18

16.72

4.5

21.68

21.87

0.32

1820

16231

(3020779) Urea [Moles/volume] in Serum or Plasma

1102

14206

0.76

16.67

5.1

7.9

8.02

9.57

mmol/l

14.96

1050

13648

(40762887) Creatinine [Moles/volume] in Blood

106

4.16

16.67

1.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

3726

42253

0.85

16.63

3.6

4.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

672

9319

0.71

16.48

8.6

10.3

16.22

16.03

1.17

665

8997

(3025468) Yersinia sp identified in Specimen by Organism specific culture

319

1928

1.67

16.47

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

320

1936

1.67

16.46

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

217

3850

0.56

16.33

1.7

2.3

131.35

129.58

g/l

0.41

111

2932

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

182

3.30

16.32

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13067

125716

1.17

16.06

18.6

20.6

332.47

332.20

g/l

3.20

13018

125125

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7265

67113

1.14

15.89

1.8

1.9

1.26

1.37

mmol/l

26.07

6107

56445

(3009508) Creatinine [Moles/volume] in Urine

5047

55755

0.86

15.80

3.2

3.5

7.63

7.49

mmol/l

1.47

4092

47408

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

844

6285

1.36

15.65

1.6

13.05

17.28

u/ml

1.24

159

1450

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

634

4502

1.42

15.62

2.7

2.4

0.00

g/l

1.12

565

3946

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3972

35207

1.17

15.27

1.7

1.8

1.03

1.18

mg/l

1.75

2953

27408

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7670

71243

1.14

15.20

5.4

6.8

1.22

1.21

mmol/l

18.15

6954

66239

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

554

3861

1.45

15.12

1.2

1.3

44.64

44.99

u/ml

0.01

366

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

653

4693

1.41

15.04

2.7

2.4

0.01

0.02

g/l

0.47

590

4226

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

591

4182

1.43

14.86

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

184

3.16

14.71

1.1

—

(3021589) Normoblasts [#/volume] in Blood

6516

70483

0.88

14.60

9.1

11.8

0.00

e9/l

3.73

4902

57643

(3002256) Pathology report gross observation

2518

21558

1.20

14.55

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

810

6063

1.35

14.54

2.6

2.4

2.82

2.88

g/l

1.13

725

5542

(44806420) Estimation of glomerular filtration rate

1842

0.40

14.51

2.1

2.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

10605

100768

1.14

14.50

4.5

4.7

5533.88

1640.88

e6/l

0.71

1350

(3024522) Salmonella sp identified in Specimen by Organism specific culture

325

2042

1.60

14.44

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4924

54201

0.87

14.21

3.0

3.4

31.29

34.06

u/l

3.45

4636

51200

(40758558) Short blood count panel - Blood

5303

48213

1.15

14.18

6.7

6.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1004

7792

1.31

14.02

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

591

4227

1.41

14.01

1.1

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12412

119307

1.15

14.01

7.9

8.6

75.31

79.01

u/l

16.33

11679

113792

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1868

15607

1.22

13.89

2.2

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

589

4217

1.41

13.89

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

159

824

1.94

13.83

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

327

2083

1.58

13.73

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

321

2041

1.58

13.59

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

1779

0.42

13.38

1.7

10.1

7.01

7.54

mmol/l

0.58

1501

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

431

6215

0.69

13.21

1.8

2.0

1.25

2.14

ug/l

1.85

384

5585

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

256

1552

1.66

13.17

1.3

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

208

3510

0.59

13.07

2.2

2.4

97.69

108.42

ug/min

0.15

116

2108

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4180

37558

1.15

13.01

1.3

1.68

1.71

u/ml

0.03

863

10349

(3019420) Tryptase [Mass/volume] in Serum or Plasma

170

923

1.85

12.87

1.5

6.09

8.15

ug/l

2.52

163

839

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

141

721

1.96

12.80

1.1

5.80

7.47

u/ml

0.39

124

(1002224) Polysomnography panel

983

7718

1.29

12.59

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

317

2.47

12.50

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

833

6409

1.32

12.41

2.5

2.4

4.16

4.25

g/l

1.65

749

5892

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

351

5200

0.67

12.41

1.5

1.8

—

32.21

—

(1761868) Lipid panel - Serum or Plasma

5606

60806

0.88

12.39

2.7

3.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

833

6416

1.31

12.32

2.5

2.4

7.06

7.39

g/l

7.36

747

5892

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

158

853

1.86

12.20

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

191

1093

1.76

12.18

1.1

25.64

19.20

u/ml

0.83

444

(3021960) Folate [Moles/volume] in Serum or Plasma

4884

44538

1.14

12.00

1.6

1.7

21.68

20.30

nmol/l

9.06

3911

37980

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

828

6397

1.31

11.98

2.5

2.4

3.56

3.70

g/l

1.96

742

5878

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

567

7671

0.73

11.94

2.9

4.1

50.96

48.14

2.09

561

7564

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1872

0.47

11.85

1.4

1.5

58.50

59.78

ug/l

0.10

1872

(3045414) Leukocytes [Presence] in Urine

1835

15561

1.20

11.62

2.2

2.1

0.00

0.02

estimate

6.85

205

3252

(3038026) Centromere Ab [Units/volume] in Serum

212

1268

1.68

11.55

1.3

1.2

35.81

54.93

u/ml

0.73

(3026493) Urate [Moles/volume] in Serum or Plasma

4609

41973

1.13

11.46

2.5

2.7

327.99

337.55

umol/l

10.13

3997

37209

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

159

883

1.81

11.26

1.1

1.23

1.10

u/l

0.81

362

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1689

14267

1.20

11.14

2.1

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2390

27326

0.85

11.12

2.8

3.6

0.83

0.82

mmol/l

10.31

2211

25820

(3012544) pH of Venous blood

1322

15926

0.82

11.06

2.9

4.1

7.38

1.12

613

9106

(3006576) Bicarbonate [Moles/volume] in Blood

504

0.18

11.06

6.2

6.5

26.61

25.06

mmol/l

—

461

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1235

0.37

11.05

1.3

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

389

2702

1.45

10.93

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

189

3116

0.60

10.90

3.2

3.5

31.41

26.16

mg/l

0.62

2145

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

138

2472

0.55

10.90

1.4

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

142

2508

0.56

10.67

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

392

2740

1.44

10.66

1.5

1.17

1.15

ratio

0.16

227

1664

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1304

15673

0.82

10.65

2.8

4.1

5.81

5.82

kpa

0.17

1278

15300

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1502

17804

0.83

10.62

1.7

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1022

8238

1.26

10.57

1.1

0.78

7.80

u/ml

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

392

2748

1.44

10.50

1.5

1.17

1.22

ratio

0.52

230

1682

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

392

2748

1.44

10.50

1.5

0.98

0.94

ratio

0.83

227

1673

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

711

5483

1.31

10.46

2.6

2.4

9.98

10.11

g/l

0.36

617

4910

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

350

5010

0.69

10.37

2.6

3.3

0.36

0.35

iu/ml

0.11

176

2771

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

2.89

10.34

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

545

4052

1.36

10.32

1.6

10413.99

13561.22

e6/l

1.43

384

2856

(3004775) Volume in Urine collected for unspecified duration

1166

0.38

10.30

2.5

2.3

623.29

663.13

0.34

821

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

120

628

1.92

10.28

2.0

2.1

41.00

40.21

g/l

0.66

120

628

(3033099) Centromere Ab [Titer] in Serum

412

2.14

10.24

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

759

9638

0.78

10.15

2.1

3.5

134.03

129.27

g/l

8.76

741

9363

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

108

2030

0.53

10.09

1.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12200

125882

0.89

10.06

17.3

19.8

13.42

13.61

67.06

12080

124327

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

681

5251

1.31

10.04

1.1

0.60

0.62

ratio

0.28

709

(3002032) Base excess in Venous blood by calculation

1275

15271

0.82

10.03

2.8

4.1

1.60

1.83

mmol/l

1.88

1159

13456

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12468

120749

1.12

9.73

4.5

4.6

14.62

14.76

pmol/l

8.35

11293

111732

(4027681) Cerebrospinal fluid IgG ratio and IgG index

163

958

1.71

9.57

1.2

0.59

0.68

ratio

0.53

106

545

(3013139) Helicobacter pylori Ag [Presence] in Stool

1362

11435

1.21

9.56

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4726

51192

0.89

9.46

2.5

2.7

61.88

65.05

u/l

0.54

4272

47521

(3005719) IgG [Mass/volume] in Serum or Plasma

1508

12797

1.20

9.43

2.8

2.9

10.41

10.50

g/l

0.36

1415

11865

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1017

8306

1.24

9.37

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

954

0.34

9.37

22.2

20.3

1330.64

2426.14

nmol/l

0.56

918

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

195

1210

1.62

9.30

1.1

8.52

8.62

iu/ml

0.02

299

(3044889) 12 lead EKG panel

10375

107835

0.90

9.27

3.7

4.1

0.18

3425.02

1.18

223

(3019150) Specific gravity of Urine by Refractometry

3324

36712

0.88

9.20

3.6

4.1

1.02

1.14

kg/l

1.09

2044

24338

(3008898) HLA-B27 [Presence]

699

5478

1.29

9.15

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

159

2.77

9.02

1.1

1.0

—

(3000494) Fungus identified in Specimen by Culture

2262

19916

1.16

8.99

1.4

1.5

—

(36304419) Bacteria [Presence] in Urine

4562

42008

1.12

8.98

3.2

0.38

279.52

estimate

0.86

161

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

154

2.80

8.97

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

889

7191

1.25

8.95

2.0

42.29

39.61

u/l

3.48

783

6435

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

917

0.35

8.94

1.4

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

1601

0.50

8.93

1.9

2.3

4.03

mmol/l

0.08

1585

(3035285) Chloride [Moles/volume] in Venous blood

1600

0.50

8.92

1.9

2.3

106.01

105.47

mmol/l

0.49

1584

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

401

2910

1.39

8.89

1.6

1.5

67.76

60.34

ug/l

0.85

324

2399

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

956

0.36

8.83

1.4

1.5

—

(40762814) Titanium [Mass/volume] in Blood

231

2.43

8.82

2.7

2.5

2.97

3.79

ug/l

1.18

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

2.80

8.81

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

161

968

1.67

8.73

1.1

4.59

7.99

nmol/l

0.61

177

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

914

0.36

8.60

19.8

14.6

720.55

2252.38

nmol/l

0.55

879

(3000850) Epithelial cells [#/volume] in Urine

3202

35319

0.88

8.59

2.5

2.8

4.77

5.76

e6/l

3.34

2838

32215

(46235355) HIV 1 and 2 tests - Meaningful Use set

3018

27201

1.13

8.46

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1569

0.51

8.42

1.9

2.3

1.20

mmol/l

0.21

1553

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

249

1673

1.50

8.40

1.6

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

269

1839

1.47

8.33

1.5

1.8

11226.67

1284.57

titre

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

367

4992

0.73

8.10

2.8

3.5

1.27

1.53

mg/l

11.97

341

4574

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1016

0.41

8.07

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

179

1132

1.59

7.97

1.3

1.2

—

(3018095) Leukocytes [#/volume] in Urine

6219

58472

1.10

7.95

4.0

51.89

95.16

e6/l

11.05

3894

41073

(3004451) EKG impression Narrative

879

0.37

7.93

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

238

3472

0.68

7.92

3.1

2.8

31.93

34.04

umol/l

0.73

212

3143

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

352

2554

1.39

7.87

1.2

0.70

1.01

0.75

(4146454) Self-monitoring of blood glucose

244

1656

1.48

7.86

2.8

2.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

123

2067

0.59

7.80

1.4

1.5

33.44

33.62

g/l

0.06

112

1889

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

511

0.20

7.73

1.1

3.5

11.92

10.40

kpa

—

511

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

510

0.20

7.71

1.1

3.5

4.65

4.97

kpa

—

510

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1094

9190

1.20

7.66

1.6

1.7

—

(3049717) Cytology report of Urine Cyto stain

686

5488

1.26

7.65

2.7

2.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

192

2.45

7.61

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

217

3186

0.68

7.49

1.3

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

582

4580

1.28

7.45

1.9

44.83

41.72

nmol/l

2.45

567

4458

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

606

4801

1.27

7.35

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

654

5232

1.26

7.31

1.8

1.18

1.20

g/l

0.73

620

5008

(37208534) Antinuclear antibody arbitrary concentration in serum

540

1.82

7.30

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

859

0.39

7.29

1.5

2.1

7.36

8.08

mmol/l

0.77

859

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

302

4157

0.72

7.23

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1215

0.49

7.22

1.1

—

(3005033) Fetal Nuchal fold Thickness US

310

2238

1.39

7.18

1.5

1.28

1.25

0.42

223

1610

(3043238) Trisomy 21 risk [Likelihood] in Fetus

322

2343

1.38

7.12

1.6

—

(3017569) Oxygen content in Arterial blood

863

0.40

7.10

2.1

2.3

16.29

15.93

0.28

863

(3023419) Bacteria identified in Sputum by Culture

132

2126

0.62

7.08

2.5

2.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

126

2051

0.61

7.07

1.3

7.18

7.34

mmol/l

0.20

106

1817

(4015189) Microbial culture of sputum

383

1.96

7.05

1.6

2.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

146

2294

0.63

7.03

4.7

6.5

10.70

11.86

mg/l

2.80

135

2127

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

686

5545

1.25

7.02

3.1

4.0

24.94

24.87

mmol/l

0.36

635

5131

(3047352) Trisomy 18 risk [Likelihood] in Fetus

314

2281

1.38

7.02

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

164

1049

1.57

7.02

1.1

—

0.33

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

179

2692

0.66

7.01

1.6

—

(3042631) Mycobacterium sp identified in Specimen

128

2071

0.62

7.00

2.8

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

634

5081

1.26

7.00

1.8

0.23

0.24

g/l

0.98

596

4844

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7818

74599

1.09

6.88

3.1

3.2

108.58

124.93

ug/l

8.89

7234

69908

(3025130) Human papilloma virus identified in Specimen

336

2479

1.36

6.84

1.7

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

319

4311

0.73

6.82

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

225

3216

0.70

6.76

1.6

2.0

0.86

0.85

nmol/l

0.09

187

2733

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

296

2144

1.39

6.75

1.1

3.55

3.61

eliau/ml

0.02

114

1011

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

251

3519

0.71

6.75

2.8

3.7

415.50

863.88

u/ml

0.63

223

3203

(40761535) Cells panel - Urine sediment

1323

11428

1.17

6.73

3.2

3.5

—

0.83

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1121

13092

0.85

6.65

2.0

2.5

0.37

0.40

e6/l

0.22

1037

12500

(3004716) Salmonella sp identified in Stool by Organism specific culture

883

7393

1.21

6.45

1.4

—

(3015736) pH of Urine

7028

66883

1.09

6.42

3.2

3.5

6.20

6.22

0.41

3399

37377

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

222

1551

1.44

6.26

1.6

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

226

3179

0.71

6.23

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

277

3763

0.73

6.17

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1485

13031

1.15

6.14

1.7

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

453

1.81

6.13

2.6

3.3

1.94

1.91

ratio

0.04

411

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

635

5171

1.24

6.12

1.2

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

161

1061

1.52

6.09

2.3

2.7

0.69

e9/l

0.07

156

1008

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

136

2095

0.65

6.05

1.4

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2318

25565

0.89

5.99

1.8

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

238

1700

1.41

5.95

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

148

2230

0.66

5.93

4.6

5.5

364.58

364.54

umol/l

0.00

116

1956

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

424

3306

1.29

5.92

2.0

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

369

2828

1.31

5.87

1.1

—

(21494755) Public health laboratory ask at order entry panel

1606

14216

1.14

5.87

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1463

0.59

5.84

1.5

1.6

35.65

31.52

0.53

862

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

152

1002

1.52

5.77

1.3

157.46

176.05

pmol/l

0.82

152

1002

(3001893) Eosinophils/Leukocytes in Pleural fluid

418

0.24

5.76

1.3

1.4

1.50

2.49

—

362

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

743

0.43

5.70

4.0

4.1

—

(3035880) pH of Pleural fluid

770

0.44

5.68

1.1

1.3

7.43

7.41

0.50

536

(3003740) Influenza virus B Ag [Presence] in Specimen

367

2826

1.31

5.66

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

560

4550

1.24

5.55

1.1

—

(40768797) Stomach Pathology biopsy report

2503

22836

1.11

5.54

1.3

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

141

2.41

5.43

1.0

1.1

0.08

0.03

u/ml

0.52

141

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

560

4562

1.24

5.43

2.1

12.32

11.44

mg/l

1.27

519

4282

(3022948) Iron [Moles/volume] in Serum or Plasma

2521

27536

0.90

5.42

2.3

2.7

14.32

13.19

umol/l

12.08

2378

25715

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8267

79526

1.08

5.39

5.7

7.5

1.22

1.21

mmol/l

17.84

7329

68851

(3036048) Francisella tularensis Ab [Titer] in Serum

364

1.84

5.34

1.1

1.2

—

836.36

—

(3036071) Salmonella sp Ab [Titer] in Serum

474

1.73

5.32

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

704

5890

1.20

5.25

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1701

18946

0.89

5.18

1.7

1.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1415

0.61

5.17

1.3

269.99

411.07

u/l

2.79

1352

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

391

4939

0.79

5.16

2.3

2.2

5665.20

5082.98

u/l

0.15

147

1888

(3007853) Bacteria identified in Skin by Aerobe culture

1701

18924

0.89

5.08

1.6

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1439

12771

1.14

5.07

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

186

1314

1.42

5.03

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.40

5.01

1.0

1.1

0.04

u/ml

0.12

(3020650) Glucose [Presence] in Urine

557

0.39

4.89

2.8

1.6

0.14

0.04

estimate

0.32

557

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2086

18974

1.11

4.87

2.6

2.8

7.02

8.45

umol/l

2.98

1853

16553

(3000919) Neutrophils/Leukocytes in Pleural fluid

375

0.27

4.86

1.3

1.4

34.58

21.80

—

340

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

422

3377

1.26

4.85

1.1

2.26

1.87

u/ml

0.30

232

1801

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1363

0.61

4.80

1.8

1.4

1.01

1.26

promille

0.83

1059

(3024354) Oxygen [Partial pressure] in Venous blood

1143

12995

0.87

4.80

2.3

3.5

4.58

4.56

kpa

0.13

1120

12655

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

157

2.23

4.73

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

321

1.84

4.73

1.1

29.78

32.22

iu/ml

0.14

321

(3030467) Casts [#/volume] in Urine by Automated count

4677

44196

1.08

4.72

3.2

3.3

0.29

0.40

e6/l

3.81

3115

32303

(3041806) Other cells [#/volume] in Blood by Manual count

380

1.77

4.69

1.5

0.56

0.51

e9/l

1.27

380

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

645

5416

1.20

4.66

1.7

1.9

—

(3042936) Bacteria identified in Isolate by Culture

2073

22701

0.90

4.65

1.7

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

123

1824

0.67

4.65

1.4

1.5

2934.40

3170.29

e6/l

0.06

1277

(3045424) Erythrocytes [Presence] in Urine

924

8013

1.16

4.55

2.2

0.00

0.24

estimate

1.08

160

2572

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

316

2462

1.29

4.55

1.2

3.17

3.84

u/ml

0.65

156

1141

(3010375) cycloSPORINE [Mass/volume] in Blood

718

0.49

4.55

25.1

29.8

117.13

114.67

ug/l

0.09

583

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3360

31372

1.09

4.54

2.8

3.1

2.44

2.45

mmol/l

6.32

2965

28287

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

261

3402

0.76

4.48

1.4

1.5

—

(3042733) HLA Ab [Presence] in Serum

548

0.42

4.46

3.4

4.9

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

105

2.48

4.44

1.5

1.4

11.70

35.71

3.24

(3009445) Proteinase 3 Ab [Units/volume] in Serum

809

6959

1.17

4.43

1.5

1.6

12.43

15.21

iu/ml

0.25

186

(3024891) Influenza virus A+B Ag [Presence] in Specimen

486

3994

1.22

4.41

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

202

2.03

4.40

1.0

1.1

0.29

0.18

u/ml

0.22

130

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

840

0.53

4.38

1.3

5.67

5.80

mmol/l

0.51

791

(3034988) Calcium [Moles/volume] in Capillary blood

275

0.29

4.35

1.4

2.0

1.14

1.18

mmol/l

—

261

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

142

984

1.45

4.33

1.5

5.60

6.01

u/l

0.49

120

854

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2366

25635

0.91

4.27

2.2

2.6

2.37

2.35

g/l

1.30

2193

23759

(3029634) Reagin Ab [Titer] in Serum by VDRL

280

2168

1.30

4.25

1.8

2.1

4.00

8.24

titre

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

629

5318

1.19

4.25

1.5

0.33

8.85

iu/ml

1.22

116

1014

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1308

0.63

4.24

1.6

—

(40757373) Influenza virus identified in Isolate

285

0.32

4.19

1.1

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

481

3973

1.22

4.18

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

235

0.26

4.16

2.7

6.1

7.17

8.41

mmol/l

—

235

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5126

48793

1.07

4.16

2.1

2.2

153.48

202.73

u/l

9.52

4850

46142

(3023487) Leukocytes [#/volume] in Peritoneal fluid

639

0.48

4.12

1.8

2.1

833.40

2984.17

e6/l

0.80

427

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

428

3501

1.23

4.10

1.9

204.48

199.38

pmol/l

0.50

402

3318

(3043410) Blood group antigens tested for on Red Blood Cells

398

0.35

4.09

1.5

1.8

—

(3013727) Leukocytes other/Leukocytes in Blood

468

0.41

4.03

3.2

3.7

41.34

52.86

1.31

454

(3022475) Manganese [Moles/volume] in Blood

2.45

4.03

1.0

1.3

0.17

0.16

umol/l

0.16

(3003888) Timothy IgE Ab [Units/volume] in Serum

361

2907

1.25

4.00

1.1

3.64

4.58

u/ml

0.89

198

1512

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

549

0.45

3.98

1.8

1.9

2681.62

13475.63

e6/l

1.62

276

(3045683) HLA typing for celiac disease panel - Blood or Tissue

135

944

1.43

3.96

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

596

1.55

3.92

2.0

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

334

1.74

3.92

1.2

339.28

318.32

pmol/l

0.08

246

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1027

9081

1.14

3.89

2.2

2.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

107

719

1.49

3.86

1.6

1.7

29.94

29.29

umol/l

0.28

101

678

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

356

0.34

3.85

1.1

—

39.21

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

261

2034

1.29

3.82

1.1

0.74

0.50

u/ml

0.26

670

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

513

4305

1.20

3.81

1.4

—

(3045788) Cell count panel - Pleural fluid

100

1478

0.67

3.80

1.5

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

272

0.33

3.79

1.7

2.0

1.17

1.19

mmol/l

—

261

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

116

1659

0.70

3.70

1.0

1.2

—

33.88

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

447

1.61

3.70

1.6

1.7

0.34

0.39

ug/l

0.61

334

(3003129) Base excess in Capillary blood by calculation

244

1894

1.29

3.70

2.0

2.3

0.68

0.57

mmol/l

0.20

238

1830

(3052592) Norovirus Ag [Presence] in Stool

253

0.32

3.67

1.0

1.3

—

(3003181) Sodium [Moles/volume] in Urine

228

2939

0.77

3.67

1.3

1.4

59.31

62.70

mmol/l

0.68

179

2345

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2190

23641

0.92

3.63

2.3

2.7

24.07

22.63

5.75

2067

22007

(3028308) Erythrocytes [#/volume] in Pleural fluid

112

1603

0.70

3.60

1.4

1.5

36031.73

56720.81

e6/l

0.90

885

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

210

1604

1.31

3.60

1.2

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

143

2.10

3.57

2.1

2.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

226

1.86

3.57

1.6

2.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

284

2258

1.26

3.57

1.1

3.89

4.57

u/ml

0.33

124

996

(3014133) Dog dander IgE Ab [Units/volume] in Serum

298

2391

1.25

3.47

1.1

3.47

3.81

u/ml

0.13

136

1170

(21494434) Karyotype in Bone marrow

179

1344

1.34

3.47

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

207

1.89

3.47

1.7

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

219

2813

0.78

3.46

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

159

1174

1.36

3.44

1.4

10.46

12.56

umol/l

6.24

149

1106

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

230

0.30

3.42

9.9

11.1

5.09

5.31

mmol/l

—

230

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

420

0.43

3.41

5.2

7.6

6.11

5.96

kpa

0.36

377

(40768806) Pleura Pathology biopsy report

109

1549

0.70

3.39

1.5

1.6

—

(3024316) Viscosity of Plasma

2.50

3.37

1.1

1.8

1.51

1.58

mpas

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

935

0.62

3.36

1.8

1.5

1.25

1.24

nmol/l

0.01

715

(3013005) Retinol [Moles/volume] in Serum or Plasma

107

742

1.44

3.35

1.6

1.8

2.03

1.97

umol/l

0.37

685

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

194

2519

0.77

3.34

1.1

83.44

5278.83

iu/ml

0.66

527

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

102

703

1.45

3.30

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

102

703

1.45

3.30

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

371

0.40

3.29

3.1

2.3

6.60

103.63

ug/l

0.68

371

(3018418) pH of Serum or Plasma

4611

48249

0.94

3.28

3.7

4.4

7.40

1.84

2939

34496

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

146

1966

0.74

3.27

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1442

15786

0.91

3.24

2.4

2.3

378.65

376.59

nmol/l

0.15

1333

14678

(3010144) Erythrocytes [#/volume] in Synovial fluid

192

1474

1.31

3.22

1.4

42407.72

130483.72

e6/l

2.76

127

983

(3035947) Staphylolysin Ab [Units/volume] in Serum

108

757

1.43

3.21

1.1

3.83

3.77

iu/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

332

2722

1.22

3.20

1.1

1.40

1.57

u/ml

0.15

167

1376

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1151

0.67

3.17

1.6

1.9

1.04

1.82

u/field

1.22

635

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1375

0.70

3.16

1.2

1.3

9.78

8.75

mmol/l

1.21

1296

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

150

1117

1.35

3.12

2.5

2.7

228.41

235.55

e6/l

0.19

130

955

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

844

7486

1.13

3.11

2.1

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

678

5926

1.15

3.11

1.9

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

341

2814

1.22

3.10

1.1

0.60

1.04

u/ml

2.07

154

1238

(44790047) Parainfluenza type 1 nucleic acid detection

161

2118

0.76

3.09

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

161

2118

0.76

3.09

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

161

2118

0.76

3.09

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

161

2118

0.76

3.09

1.4

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

466

5465

0.85

3.07

2.5

2.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

790

0.61

3.07

1.3

1.9

152.48

129.65

umol/l

0.14

395

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

298

0.37

2.99

6.7

6.6

10.64

10.48

0.09

298

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

123

1672

0.73

2.97

1.4

1.3

1.38

1.49

nmol/l

0.41

102

1507

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

296

3605

0.82

2.97

3.9

5.9

503.74

1476.80

iu/ml

1.15

533

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

174

1335

1.31

2.96

1.1

295.21

291.17

mg/l

0.26

156

1212

(3044007) Cell count panel - Peritoneal fluid

538

0.54

2.90

1.8

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

665

1.43

2.88

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

120

876

1.37

2.86

1.1

1569.99

1544.79

miu/ml

0.08

120

876

(3015377) Calcium [Moles/volume] in Serum or Plasma

5726

55206

1.06

2.86

3.3

3.6

2.37

2.36

mmol/l

7.96

4957

50432

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

543

1.48

2.85

1.6

2.0

9.45

9.11

mg/l

0.21

454

(3001186) Copper [Moles/volume] in Serum or Plasma

438

1.53

2.85

1.4

1.3

17.37

16.74

umol/l

0.50

380

(3008116) Ketones [Moles/volume] in Urine by Test strip

360

1.59

2.82

1.2

1.5

0.27

0.31

mmol/l

0.10

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

172

0.29

2.81

1.6

2.5

0.60

0.61

u/field

—

172

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

174

0.29

2.80

1.6

1.2

5.24

5.96

mmol/l

—

174

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.40

2.79

1.0

1.4

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

399

0.48

2.79

1.1

1.3

53.09

40.43

0.61

267

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

669

0.60

2.77

3.3

3.4

1.61

1.30

0.61

669

(3024471) HLA-A [Type]

514

0.54

2.73

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

211

1681

1.26

2.71

1.7

1.8

306.53

358.84

mu/l

2.81

172

1324

(3039162) Centromere protein B Ab [Units/volume] in Serum

266

2175

1.23

2.70

1.1

1.3

76.98

62.15

u/ml

—

139

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1337

12268

1.10

2.69

1.4

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

142

1079

1.32

2.63

2.3

2.5

455.14

526.22

e6/l

1.35

119

870

(3038071) Oxygen [Partial pressure] in Mixed venous blood

376

0.48

2.62

5.2

7.3

5.03

5.42

kpa

0.73

376

(3024666) Lithium [Moles/volume] in Serum or Plasma

913

0.67

2.60

10.8

13.6

0.60

0.63

mmol/l

0.58

833

(3013826) Glucose [Moles/volume] in Serum or Plasma

8940

91460

0.95

2.60

4.2

5.2

6.40

6.68

mmol/l

43.57

8478

86863

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1245

11407

1.10

2.60

1.2

162.09

138.02

u/ml

1.09

423

4395

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

178

1397

1.28

2.60

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

944

10425

0.90

2.57

3.1

3.8

5.10

5.15

kpa

1.58

889

9993

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

222

1.71

2.56

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

388

1.52

2.49

1.2

1.3

—

(3000492) Spirometry study

1717

15991

1.08

2.47

1.5

—

20.46

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

432

0.53

2.45

1.3

1.2

4.15

11.83

pmol/l

—

160

(3002621) Streptococcal DNAse B [Units/volume] in Serum

144

1.88

2.45

1.0

1.1

169.80

354.84

u/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

498

4343

1.15

2.44

2.7

3.1

3.23

2.27

index

0.45

233

2200

(3026470) Cobalt [Mass/volume] in Blood

118

888

1.33

2.38

2.4

2.2

5.50

3.60

ug/l

0.94

108

826

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

557

1.42

2.37

1.3

1.2

108.48

110.63

0.33

497

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

591

1.41

2.36

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

591

1.41

2.36

2.0

2.2

—

(3024932) HLA-DR beta [Type]

503

0.58

2.36

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

395

3396

1.17

2.35

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

155

1967

0.79

2.35

1.9

2.5

1.05

1.21

g/24h

0.23

1171

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

536

4713

1.14

2.35

2.4

2.5

180.07

193.16

3.31

504

4480

(3005322) IgE [Units/volume] in Serum or Plasma

1191

10950

1.09

2.34

1.3

186.23

243.76

u/ml

1.31

1120

10180

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

218

1778

1.23

2.32

1.1

98.52

96.87

0.45

200

1675

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1250

0.73

2.31

1.3

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

112

1.97

2.29

1.0

1.2

0.49

0.67

iu/ml

0.41

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

191

1538

1.24

2.29

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

404

1.49

2.29

1.4

1.6

49.58

137.45

au/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

253

1.62

2.29

1.1

1.65

8.04

u/ml

1.09

168

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

109

817

1.34

2.27

1.3

4.21

4.40

umol/l

0.28

727

(3027231) Wheat IgE Ab [Units/volume] in Serum

301

1.56

2.26

1.0

1.1

1.07

1.82

u/ml

0.27

256

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

329

2799

1.18

2.25

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

166

1319

1.26

2.24

1.1

1.2

183.33

204.07

titre

0.12

221

(3001556) Androgen free Index in Serum or Plasma

113

1.95

2.24

1.6

1.2

—

(3025577) Chromium [Mass/volume] in Blood

114

863

1.32

2.23

2.3

2.2

3.35

2.38

ug/l

0.96

718

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

598

1.39

2.22

2.0

2.2

—

(40768793) Breast Pathology biopsy report

478

4191

1.14

2.20

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

224

2710

0.82

2.20

1.5

1.3

33.56

30.86

u/l

0.15

193

2343

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

499

1.42

2.19

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

289

2441

1.19

2.16

1.4

28.75

31.47

u/l

0.64

230

1985

(3002719) Hemoglobin [Mass/volume] in Urine

3.69

2.15

1.0

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

387

0.54

2.14

1.1

1.4

29.18

25.30

g/l

0.53

297

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

596

1.38

2.11

1.4

1.2

0.30

g/l

0.10

478

(4038314) Semen analysis, post vasectomy

2.21

2.10

1.1

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

798

8786

0.90

2.10

3.0

3.6

1.40

1.79

mmol/l

3.10

602

6548

(3017354) Segmented neutrophils/Leukocytes in Blood

211

1736

1.22

2.10

3.7

3.5

54.69

57.23

0.99

187

1510

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

588

1.38

2.10

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

237

2836

0.83

2.09

2.5

2.8

529.62

3055.80

u/ml

1.03

148

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

811

0.69

2.08

1.5

1.6

7.71

8.06

mmol/l

0.77

774

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

471

1.42

2.08

1.1

1.3

148.93

128.32

nmol/l

0.59

347

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.56

2.07

1.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

2.26

2.07

1.5

1.4

436.29

969.37

nmol/l

1.25

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.26

2.07

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.26

2.07

1.0

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

285

2417

1.18

2.06

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

193

2349

0.82

2.05

1.3

297.69

373.76

pmol/l

0.81

175

2002

(3048929) Epstein Barr virus Ab [Presence] in Serum

556

4951

1.13

2.04

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

225

2698

0.83

2.04

3.6

3.2

0.73

0.81

nmol/l

2.66

174

2166

(4195642) Thrombophilia screening test

275

2327

1.18

2.04

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

275

2328

1.18

2.03

1.1

121.96

117.69

1.35

243

2111

(3017509) Phencyclidine [Presence] in Urine

159

0.38

2.01

1.8

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

159

0.38

2.01

1.2

—

0.45

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

161

1992

0.81

2.01

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

117

905

1.29

2.00

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

122

949

1.29

2.00

3.6

3.3

22.13

26.64

mu/l

0.92

113

900

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

509

1.40

1.99

1.2

1.1

90.67

88.58

0.17

233

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

509

1.40

1.99

1.1

1.0

5.81

10.94

u/ml

2.25

322

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

493

1.40

1.98

1.1

1.2

1158.82

976.24

titre

0.71

101

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

145

1154

1.26

1.98

1.1

—

0.57

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

294

2513

1.17

1.95

1.2

3.07

3.38

u/ml

0.14

107

921

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.02

1.95

1.1

1.0

2.06

0.28

u/ml

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

129

1016

1.27

1.93

1.2

1.3

74.29

61.23

titre

—

(3009343) pH of Capillary blood

931

10119

0.92

1.90

3.1

3.8

7.42

4.05

726

8453

(3026389) Candida sp identified in Specimen by Organism specific culture

211

2524

0.83

1.89

1.3

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1071

11565

0.92

1.88

1.6

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

139

0.36

1.87

1.6

1.3

21.88

21.10

mmol/l

—

107

(21494815) CD4 cells/Lymphocytes in Specimen

168

1370

1.23

1.86

1.9

2.2

42.02

39.22

1.64

163

1342

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

342

1.46

1.83

1.2

1.1

103.11

78.92

—

106

(3048879) Bone marrow aspiration report

392

1.43

1.82

2.1

2.0

—

2.00

—

(3005570) Glucose [Moles/volume] in Urine

122

1537

0.79

1.82

1.8

2.0

—

0.86

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

635

0.68

1.82

3.4

1.7

9599.18

359.32

pmol/l

—

106

(3014599) Egg white IgE Ab [Units/volume] in Serum

119

936

1.27

1.82

1.0

1.1

2.25

6.36

u/ml

0.45

230

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

141

1132

1.25

1.81

1.3

1.2

—

(4198724) Urine methamphetamine measurement

646

0.68

1.81

1.7

2.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.88

1.80

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

573

0.66

1.79

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

319

2767

1.16

1.78

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

139

1118

1.25

1.77

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

479

1.38

1.76

1.3

38.41

39.82

g/l

0.30

251

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

102

1.86

1.75

1.0

1.1

—

(4268621) Lupus anticoagulant assay

213

1791

1.19

1.75

2.2

2.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

232

0.47

1.74

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

411

0.61

1.74

1.1

1.3

2.27

273.11

ug/l

2.54

222

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.50

1.73

1.0

1.1

2.67

3.08

—

(3008295) Osmolality of Serum or Plasma

143

1757

0.81

1.72

1.8

1.4

278.79

278.67

mosm/kgh2o

0.02

1339

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.70

0.0

8.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

1.70

0.0

2.2

—

4.41

—

(3023383) Lactate [Moles/volume] in Pleural fluid

433

0.62

1.70

1.2

1.3

2.99

3.48

mmol/l

0.62

397

(3015171) Extractable nuclear Ab [Units/volume] in Serum

734

6713

1.10

1.70

1.3

0.41

1.08

u/ml

2.30

552

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

340

1.44

1.69

1.2

62.29

72.15

—

100

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

130

1044

1.25

1.69

1.2

1.3

20.00

535.35

titre

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

370

0.59

1.68

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

192

1607

1.20

1.67

3.8

3.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5753

56044

1.04

1.67

3.3

3.5

1.23

2.07

e6/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

198

2350

0.84

1.67

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.58

1.65

1.0

2.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

108

852

1.27

1.64

1.0

0.30

0.99

u/ml

0.99

208

(3014111) Lactate [Moles/volume] in Serum or Plasma

1512

14252

1.07

1.63

6.1

8.1

1.27

1.33

mmol/l

0.87

1473

13999

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

127

1.73

1.63

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

173

1.62

1.63

2.1

2.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

189

1.59

1.62

1.1

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

302

1.46

1.62

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

665

0.71

1.61

3.0

4.8

4962.79

611.39

mg/l

0.42

478

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.14

1.60

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

143

1.68

1.60

1.0

1.1

2.07

1.66

iu/ml

0.56

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.33

1.58

1.0

1.1

0.17

0.22

g/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

350

0.60

1.57

1.2

1.3

1.20

1.18

mmol/l

0.64

350

(40768446) Kidney Pathology biopsy report

672

0.71

1.56

1.3

1.7

—

(4024509) Urine culture

794

7322

1.09

1.55

1.9

—

(37021550) Renin [Units/volume] in Plasma --upright

305

1.44

1.55

1.3

93.41

70.82

mu/l

0.19

229

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

103

815

1.27

1.55

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.11

1.54

1.0

1.1

4.99

0.53

u/ml

0.43

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

500

1.34

1.54

1.5

1.1

89.23

90.44

0.07

234

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.88

1.54

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

331

2915

1.14

1.53

1.6

0.73

0.75

g/l

0.14

280

2256

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

1.52

0.0

1.3

—

132.75

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

761

8249

0.92

1.52

2.1

3.1

1.13

1.26

3.48

756

8209

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2299

24019

0.95

1.50

2.0

2.2

29.31

29.53

1.14

2258

23392

(3017817) Protein [Mass] in Urine collected for unspecified duration

109

1355

0.80

1.50

1.9

2.6

770.66

1072.10

1.65

109

1343

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

1.52

1.50

1.1

—

(3044927) Protein electrophoresis panel - Urine

175

1470

1.19

1.50

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

131

1.68

1.49

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

131

1.68

1.49

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2464

23624

1.05

1.48

1.6

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

826

0.75

1.48

1.5

1.7

3.97

7.32

nmol/l

0.41

680

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

767

1.27

1.48

2.5

1.9

141.30

152.11

0.73

722

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

116

1.72

1.48

1.1

1.2

—

(3011048) Pyruvate [Moles/volume] in Blood

1.81

1.46

1.6

1.2

69.53

80.89

umol/l

0.89

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

255

0.55

1.46

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

301

2645

1.14

1.46

1.2

—

(3036489) Thrombin time

662

6082

1.09

1.43

1.8

2.1

20.48

21.06

1.93

584

5356

(3029612) Listeria sp Ab [Titer] in Serum

2.73

1.43

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

118

959

1.23

1.43

1.0

1.1

1.01

1.87

u/ml

0.55

310

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.79

1.42

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

137

1132

1.21

1.42

1.2

1.1

384.42

365.30

nmol/l

0.51

128

973

(3020491) Glucose [Moles/volume] in Blood

129

1060

1.22

1.41

1.4

1.8

6.28

6.73

mmol/l

2.03

109

735

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

654

7108

0.92

1.41

1.7

1.35

1.56

g/l

8.78

550

6152

(40768795) Lymph node Pathology biopsy report

144

1726

0.83

1.41

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

248

2159

1.15

1.39

1.2

1.1

—

(4212803) Bone marrow aspirate examination

127

1.65

1.36

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

211

1819

1.16

1.36

1.3

—

(3014891) Appearance of Pleural fluid

162

0.49

1.35

2.0

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

460

4172

1.11

1.33

1.1

3.51

7.46

eliau/ml

1.84

515

(3006922) Hepatitis E virus Ab [Presence] in Serum

160

1352

1.19

1.32

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

781

1.24

1.30

4.1

6.1

11766.80

5530.73

u/ml

—

131

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.74

1.30

1.2

1.5

346.94

303.80

umol/24h

0.52

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

225

1.47

1.30

1.1

1.0

12.35

8.03

u/ml

0.25

225

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.84

1.29

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.76

1.28

3.6

3.9

—

0.00

estimate

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

244

0.57

1.28

1.8

1.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1171

12403

0.94

1.28

2.1

2.3

7.68

7.62

ug/l

0.03

994

11019

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

906

0.78

1.27

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

456

1.32

1.27

2.0

2.2

0.18

0.41

e9/l

0.70

214

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3096

29956

1.04

1.26

3.6

3.9

322.57

434.79

ng/l

1.06

2354

22859

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

163

1388

1.18

1.25

1.2

122.72

108.99

pmol/l

1.08

163

1388

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

563

1.28

1.25

1.1

—

(3003694) ABO and Rh group [Type] in Blood

4344

44587

0.97

1.24

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

562

0.73

1.23

2.7

3.2

28.33

28.25

umol/l

0.01

425

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

100

1.70

1.23

4.7

6.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

364

1.35

1.22

1.1

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.63

1.21

1.2

1.0

4500.00

2913.68

titre

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

6994

71204

0.97

1.21

4.2

5.2

36.93

35.83

g/l

64.36

6541

67028

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

744

1.24

1.21

1.2

10.26

10.23

mm/h

0.01

744

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

254

1.42

1.21

1.3

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

348

1.35

1.20

1.1

—

21.20

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

156

1.54

1.19

1.0

0.00

0.18

u/ml

0.97

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

1412

0.83

1.18

2.8

3.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

784

0.78

1.18

1.8

2.2

42.77

38.59

umol/l

—

(3036603) Volume of Urine

148

1259

1.18

1.17

1.7

1.6

2038.98

1975.85

0.42

148

1227

(3019174) dRVVT (LA screen)

133

1.58

1.17

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

130

0.46

1.15

1.0

1.1

—

18.30

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

198

0.56

1.15

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

274

1.39

1.14

1.0

1.1

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

1.14

0.0

8.7

—

51.69

—

(3032057) Clostridioides difficile [Presence] in Stool

300

1.37

1.14

1.8

—

(3011985) Renin [Units/volume] in Plasma

223

2530

0.88

1.13

1.5

65.78

63.45

mu/l

0.06

197

2268

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

934

0.80

1.13

1.1

1.04

1.06

ratio

1.70

773

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

216

1.44

1.13

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

275

1.38

1.12

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

275

1.38

1.12

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

221

0.59

1.11

1.2

2.2

0.51

1.11

mmol/l

—

150

(3035350) Ketones [Presence] in Urine by Test strip

8281

84021

0.97

1.11

3.5

3.9

9.03

3.36

estimate

0.77

871

17921

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

477

5189

0.92

1.11

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1195

0.83

1.11

2.0

2.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

200

2278

0.88

1.09

2.9

2.7

5.01

842.30

u/ml

1.29

200

2256

(4034850) Laboratory test

513

4734

1.09

1.08

7.9

9.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

172

1493

1.15

1.07

3.7

3.8

—

(3009677) Dengue virus Ab [Presence] in Serum

1.86

1.07

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

153

1.50

1.05

1.0

0.01

0.06

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

980

0.82

1.05

1.2

1.1

16.25

23.69

u/l

2.07

873

(3020630) Protein [Mass/volume] in Serum or Plasma

1388

13256

1.05

1.03

2.7

66.89

66.43

g/l

1.73

1249

12236

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

197

1732

1.14

1.03

1.1

0.89

1.98

iu/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

1062

1.18

1.03

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.27

1.03

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.27

1.03

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.27

1.03

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.27

1.03

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.27

1.03

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.27

1.03

2.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

349

3173

1.10

1.03

1.9

5.30

5.09

mmol/24h

0.57

304

2838

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

988

0.82

1.03

1.2

1.1

76.38

82.60

u/l

0.50

877

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

318

2879

1.11

1.02

3.4

3.8

30.07

35.99

u/ml

0.32

308

2787

(21494890) Protein electrophoresis panel - 24 hour Urine

140

1625

0.86

1.01

2.0

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

553

5950

0.93

1.01

3.5

3.7

411.83

1746.19

u/ml

1.77

478

5136

(3004809) Band form neutrophils/Leukocytes in Blood

240

2686

0.89

1.01

3.6

3.5

1.69

1.58

0.14

218

2438

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

1.00

1.2

1.1

28.09

62.57

umol/24h

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

239

1.38

1.00

1.8

2.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

171

1953

0.87

0.99

1.5

1.6

46.30

57.09

3.09

121

1201

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

520

1.25

0.99

1.1

1.3

3.90

26.38

5.75

(3033086) Enterovirus Ab [Titer] in Serum

1.84

0.98

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.17

0.98

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.17

0.98

1.0

2.79

0.53

u/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

425

4613

0.92

0.97

1.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.97

0.0

1.5

—

437.27

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

970

0.82

0.97

2.9

2.8

41.79

38.94

0.53

541

(3042111) Morphology [Interpretation] in Bone marrow Narrative

234

2615

0.89

0.97

1.4

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1895

18263

1.04

0.97

1.5

1.6

—

(3000330) Specific gravity of Urine by Test strip

805

7591

1.06

0.96

2.9

3.3

1.02

ratio

2.34

694

6846

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

1.5

—

1702.00

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2428

25058

0.96

1.6

1.7

1043.76

1163.94

nmol/l

8.75

1672

19185

(3034274) Bile acid [Moles/volume] in Serum --fasting

189

1669

1.13

0.95

2.0

2.1

5.34

8.47

umol/l

2.99

136

1221

(3002582) Erythrocytes [#/volume] in Urine

5210

51099

1.03

0.95

3.3

3.4

62.43

75.74

e6/l

0.22

3673

38962

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.61

0.93

1.1

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

101

1.58

0.93

1.3

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5727

58283

0.97

0.92

3.3

3.7

33.47

63.57

ng/l

2.32

3751

39585

(3020961) Endomysium IgA Ab [Titer] in Serum

819

7743

1.06

0.91

1.1

148.24

197.88

titre

0.42

216

(3028433) Virus identified in Specimen by Culture

499

1.24

0.91

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

135

1169

1.16

0.91

1.1

1.2

83.02

81.78

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

786

0.81

0.90

1.1

1.3

94.08

63.80

6.67

(3011412) CD3 cells [#/volume] in Blood

175

1547

1.13

0.88

2.3

2.4

1197.87

1202.06

e6/l

0.03

154

1365

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

109

1272

0.86

0.88

2.0

2.3

18.96

17.99

nmol/l

0.55

104

1199

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

127

1.50

0.88

1.4

1.6

0.69

1.65

mg/l

1.46

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

155

0.58

0.88

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

102

1196

0.85

0.88

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

821

1.18

0.88

1.9

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

821

1.18

0.88

1.9

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

821

1.18

0.88

1.9

2.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

237

1.35

0.87

2.5

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

193

0.62

0.87

1.2

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

144

1.46

0.87

1.0

0.10

0.60

u/ml

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1357

13024

1.05

0.86

2.8

2.7

72.41

67.38

ml/min/173m2

5.97

519

5451

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

823

1.18

0.86

1.9

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

571

0.79

0.85

1.4

14.71

15.30

pmol/l

0.39

471

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.94

0.84

1.0

1.1

—

(4133840) Spirometry

400

0.75

0.83

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

470

1.23

0.82

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

597

1.21

0.82

1.2

0.09

0.22

g/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

188

1.38

0.82

1.4

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

357

3296

1.08

0.81

1.2

1.4

9.01

25.51

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

1055

0.85

0.79

1.1

1.2

39.91

34.49

mmol/l

1.07

923

(3042517) Benzodiazepines panel - Urine

176

0.62

0.79

1.2

2.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

637

1.19

0.79

1.7

1.4

38.60

34.31

nmol/l

0.54

567

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

707

0.82

0.79

1.9

2.1

24.94

136.78

ug/min

2.28

161

(3024928) Oxygen saturation in Venous blood

427

3976

1.08

0.78

1.9

3.5

60.62

61.97

0.62

418

3849

(3035637) Corticotropin [Mass/volume] in Plasma

199

2210

0.90

0.78

1.5

24.72

29.52

ng/l

1.55

199

2203

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

546

1.21

0.78

3.4

3.7

8.59

8.61

mg/l

0.01

441

(3024263) Appearance of Synovial fluid

776

1.17

0.78

1.6

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

625

5898

1.06

0.78

1.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

313

1.28

0.77

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

100

0.50

0.77

2.4

2.2

0.60

0.61

ug/l

—

100

(3014271) Vancomycin [Susceptibility]

612

1.19

0.76

2.5

2.9

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

108

936

1.15

0.76

2.1

2.2

99.85

97.79

0.28

100

875

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

235

1.32

0.75

1.0

78.20

78.67

ug/l

0.02

185

(40765089) Chromosome analysis panel - Blood by G-banded

386

1.24

0.75

1.0

—

(3025941) Bacteria identified in Stool by Culture

910

8691

1.05

0.74

1.2

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

461

4317

1.07

0.74

1.4

10.78

11.17

u/l

0.23

366

3442

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

602

5689

1.06

0.73

1.8

2.3

168.07

588.85

ug/l

10.20

552

5392

(3037756) Immunofixation for Serum or Plasma

302

3270

0.92

0.72

1.9

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

261

2843

0.92

0.71

1.3

—

14.60

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.71

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

546

5151

1.06

0.71

1.4

283.49

274.85

ug/g

0.45

299

2998

(44816559) Phosphatidylethanol [Mass/volume] in Blood

643

6777

0.95

0.70

1.7

0.28

0.31

mg/l

0.79

274

3223

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

536

1.19

0.69

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

137

1538

0.89

0.68

1.2

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

319

1.25

0.68

1.5

1.9

3.70

3.04

ug/l

0.15

188

(3000093) Morphology [Interpretation] in Blood Narrative

165

1484

1.11

0.68

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

110

1.45

0.68

1.0

1.1

0.02

0.22

u/ml

1.83

110

(3019768) Coxiella burnetii Ab [Presence] in Serum

102

1.47

0.67

1.1

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

485

0.80

0.67

1.1

1.6

—

173.63

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.63

0.66

1.1

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

153

1.37

0.66

1.0

1.1

5.33

5.11

u/ml

0.01

121

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.79

0.66

1.0

0.03

0.05

u/ml

—

(3017732) Neutrophils [#/volume] in Blood

2123

20678

1.03

0.65

3.0

3.2

4.25

4.42

e9/l

0.38

1588

18064

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1851

19036

0.97

0.64

1.6

1.8

1.37

1.45

5.82

1624

16651

(3001964) Herpes simplex virus Ag [Presence] in Specimen

440

1.21

0.64

1.3

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

537

5084

1.06

0.64

2.0

2.3

94.43

93.16

0.76

518

4895

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

119

1056

1.13

0.63

1.2

1.3

16.23

23.35

u/l

2.22

872

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

355

3321

1.07

0.62

1.2

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

1724

17735

0.97

0.62

2.3

2.6

1.66

1.79

7.61

1509

15927

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

121

1.41

0.62

1.4

1.6

0.72

0.63

mg/l

0.11

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

121

1.41

0.62

1.4

1.6

4.57

3.96

mg/l

0.15

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

121

1.41

0.62

1.4

1.6

2.03

1.86

mg/l

0.07

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

101

0.59

0.62

1.7

1.2

27.00

1044.14

u/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

297

1.25

0.62

1.9

1.4

15058.33

278744.52

u/ml

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.60

0.61

1.1

1.3

1.30

1.37

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

851

8167

1.04

0.60

1.4

31.18

29.92

iu/l

0.49

724

6984

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

97.47

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.2

—

0.53

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.7

—

(3026726) Creatinine [Moles/volume] in Specimen

139

0.65

0.60

1.3

2.6

527.22

392.71

umol/l

—

133

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

328

3506

0.93

0.59

1.5

1.7

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.58

0.0

1.1

—

0.56

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

219

1.28

0.58

1.2

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.71

0.57

1.0

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.71

0.57

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

346

1.21

0.57

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

669

0.85

0.57

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

329

1.22

0.55

1.2

1.1

2.61

0.66

umol/24h

0.47

152

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

120

1078

1.11

0.54

1.3

75.66

88.19

u/l

1.24

103

910

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

349

1.20

0.53

1.1

—

(3013762) Body weight Measured

1.54

0.53

1.3

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

327

0.79

0.52

6.5

4.7

58.31

57.71

u/l

0.01

320

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.62

0.52

5.7

4.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

587

0.85

0.51

2.7

0.61

mmol/l

0.21

587

(3017315) Amylase [Enzymatic activity/volume] in Urine

837

1.12

0.51

1.3

1.2

304.48

385.97

u/l

0.40

766

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

661

0.86

0.51

1.0

1.1

104.45

95.40

1.27

527

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.47

0.50

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.47

0.50

1.0

0.02

0.07

u/ml

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

196

1813

1.08

0.50

1.4

6.42

6.79

g/l

0.91

163

1303

(4035726) Immunohistochemistry procedure

1485

14468

1.03

0.49

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

188

1741

1.08

0.48

2.3

2.4

36.17

26.27

iu/ml

0.36

194

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

264

2476

1.07

0.48

1.5

1.4

0.32

0.36

nmol/l

0.70

202

1822

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

308

1.20

0.47

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

432

4535

0.95

0.47

1.7

2.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

195

1811

1.08

0.46

1.4

0.35

0.41

g/l

2.02

163

1300

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

469

4912

0.95

0.46

1.3

218.11

222.77

miu/ml

0.11

233

2204

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

124

1129

1.10

0.46

1.0

772.98

739.56

ng/l

0.31

796

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

175

1619

1.08

0.46

1.8

1.4

3.44

3.91

ug/l

0.39

151

1360

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4006

40606

0.98

0.45

2.2

2.4

2.59

2.78

mg/l

5.84

3293

35292

(3023520) Reticulocytes [#/volume] in Blood

1341

13759

0.97

0.45

2.3

2.6

66.68

70.23

e9/l

3.51

928

10141

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

124

1132

1.10

0.45

1.0

37.89

42.14

ng/l

0.72

815

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

186

0.75

0.44

2.0

1.9

1.79

1.68

mg/l

0.10

158

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

767

0.89

0.43

1.4

1.8

0.90

2.85

u/field

4.39

550

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

123

1126

1.09

0.42

1.0

285.15

329.69

ng/l

1.53

825

(3008536) Aspergillus sp Ab [Presence] in Serum

339

0.83

0.42

2.2

—

(3017704) Immunofixation for Urine

797

0.89

0.42

1.8

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1007

0.90

0.42

6.9

7.1

45.87

98.05

ug/l

0.48

650

(3028192) IgG subclass 2 [Mass/volume] in Serum

194

1812

1.07

0.42

1.4

2.84

2.91

g/l

0.27

163

1304

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.1

—

293.27

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.41

0.0

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.41

0.0

1.2

—

36.42

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.41

0.0

2.5

—

8.68

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

107

976

1.10

0.40

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

163

1515

1.08

0.40

4.7

5.4

39.04

103.49

u/ml

3.38

493

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1643

16780

0.98

0.40

3.9

4.4

12.23

25.05

ug/l

1.30

1259

13635

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

653

1.12

0.40

2.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.40

0.0

1.2

—

69.04

—

(3016031) Almond IgE Ab [Units/volume] in Serum

106

1.32

0.39

1.1

1.0

0.07

0.60

u/ml

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

107

979

1.09

0.39

1.3

1.5

30.37

23.52

umol/l

1.18

908

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1032

0.91

0.38

1.6

1.5

7.57

6.68

u/l

0.25

816

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.38

0.38

14.6

8.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.33

0.37

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

736

0.90

0.37

1.1

8.90

12.64

u/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

115

0.70

0.37

2.4

5.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

309

2947

1.05

0.35

1.2

497.67

303.96

titre

0.40

231

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1546

15769

0.98

0.35

2.4

2.3

0.23

0.21

g/l

12.55

1438

14776

(4062490) Immunoglobulin typing, IgG

189

1778

1.06

0.35

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1037

10118

1.03

0.35

1.9

1.37

1.30

g/l

0.45

943

9350

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

108

1.30

0.35

1.0

1.1

7.79

11.06

u/l

0.64

108

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

134

0.75

0.34

1.7

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

227

1.19

0.34

2.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

156

0.77

0.34

1.9

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

167

0.78

0.34

2.2

3.3

0.71

1.09

mg/l

—

119

(3032868) Hemoglobin electrophoresis panel in Blood

144

0.76

0.33

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

146

1366

1.07

0.33

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

146

1366

1.07

0.33

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

146

1366

1.07

0.33

1.8

1.7

—

(3012898) Urea [Moles/volume] in Urine

166

0.78

0.33

1.5

231.23

169.16

mmol/l

1.33

147

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.70

0.33

1.3

1.5

826.65

483.85

nmol/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.68

0.33

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

317

0.85

0.32

2.5

2.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

127

1184

1.07

0.32

1.4

1.5

21.57

23.73

u/ml

0.17

216

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

146

1.23

0.32

1.0

1.1

0.02

1.87

u/ml

1.90

118

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

331

3176

1.04

0.31

1.1

1.3

254.11

267.98

u/ml

0.38

217

1986

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

484

1.12

0.31

1.0

0.34

0.70

u/ml

0.81

472

(1617658) Protocol used for examination of sentinel lymph nodes

137

1283

1.07

0.31

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

993

1.08

0.31

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

459

4748

0.97

0.30

3.5

3.3

3.42

3.55

ratio

0.03

249

2722

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

405

3906

1.04

0.30

1.4

1.5

107.50

154.99

pmol/l

1.72

396

3808

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

734

1.09

0.30

1.1

168.23

184.01

iu/ml

0.14

725

(44813793) Dust mix specific IgE antibody measurement

127

1188

1.07

0.30

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

8258

83041

0.99

0.30

3.5

3.9

0.00

estimate

0.07

844

17518

(3012494) Peanut IgE Ab [Units/volume] in Serum

409

0.88

0.29

1.1

0.90

10.47

u/ml

0.61

224

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

106

0.75

0.29

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

109

0.73

0.29

1.5

1.9

—

(3013637) Mi-2 Ab [Presence] in Serum

470

1.11

0.27

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

470

1.11

0.27

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

470

1.11

0.27

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

470

1.11

0.27

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

313

3015

1.04

0.26

1.2

1.5

146.79

151.22

au/ml

0.30

119

836

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.19

0.26

1.1

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.68

0.26

1.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

128

1357

0.94

0.26

1.5

1.8

3.25

3.86

mg/l

2.01

122

1306

(4281824) Cell count and differential, peritoneal fluid

186

1951

0.95

0.25

1.1

—

(40768441) Liver Pathology biopsy report

119

1264

0.94

0.25

1.5

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.25

0.25

1.0

1.1

8.34

8.58

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.23

0.25

1.0

1.1

23.34

20.87

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.23

0.25

1.0

1.1

37.61

36.42

—

(3020393) Adenovirus Ag [Presence] in Stool

151

1.19

0.25

1.1

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

174

1825

0.95

0.24

1.3

1.2

41.40

30.93

nmol/l

—

(3013466) aPTT in Blood by Coagulation assay

0.71

0.24

1.2

1.1

35.57

36.70

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

152

1.18

0.23

1.0

0.03

0.10

u/ml

0.96

101

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

143

1.19

0.23

1.0

1.1

105.41

93.99

titre

0.15

143

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

106

1.23

0.23

1.3

0.81

1.05

ml/s/173m2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

179

0.84

0.23

1.4

1.2

64.07

68.78

ug/l

0.08

179

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

125

1186

1.05

0.22

3.9

3.6

103.61

163.17

nmol/l

1.69

125

1175

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

257

2481

1.04

0.21

1.3

0.58

2.46

nmol/l

1.30

243

2394

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

39.11

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.09

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

196.73

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

17.36

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

8.1

—

91.86

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

103

0.78

0.21

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

90.80

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.4

—

84.50

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

330

3399

0.97

0.20

1.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.25

0.20

1.1

—

22.15

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

183

1.15

0.20

1.2

—

(3001729) Color of Synovial fluid

114

0.79

0.20

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

191

1839

1.04

0.19

1.2

52.98

63.07

u/l

3.51

171

1603

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1093

10771

1.02

0.19

3.2

3.5

4.52

4.47

pmol/l

0.97

947

9706

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

280

1.11

0.18

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

1.21

0.17

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

971

9573

1.02

0.17

8.1

10.0

24.39

24.29

mmol/l

0.55

944

9412

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

129

1.16

0.17

1.8

2.6

—

(3000991) Gas panel - Venous blood

1398

13823

1.01

0.16

7.1

9.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

793

0.95

0.16

1.3

1.2

145.03

161.76

mmol/24h

1.36

793

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

120

0.83

0.16

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

223

2163

1.03

0.16

1.3

0.27

0.20

nmol/l

0.35

171

1679

(40758358) Immune stain study

1.16

0.16

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

679

0.94

0.16

2.8

2.4

50.56

52.01

umol/l

0.16

593

(3003577) Lead [Moles/volume] in Blood

130

0.85

0.16

2.3

1.3

0.22

0.16

umol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.78

0.15

1.0

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

149

1.14

0.15

1.0

0.19

0.65

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

678

0.94

0.15

1.7

1.6

3993.85

3318.88

titre

0.29

107

(3034426) Prothrombin time (PT)

516

1.07

0.15

1.1

1.2

27.09

28.31

1.28

516

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.14

0.15

1.0

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

298

2909

1.02

0.15

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

298

2909

1.02

0.15

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.10

0.15

1.2

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

205

1991

1.03

0.14

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

236

1.10

0.14

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

358

0.92

0.14

1.3

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.08

0.14

1.1

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.18

0.14

1.1

38.60

24.72

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.18

0.14

1.1

26.20

23.16

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

270

2765

0.98

0.14

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

245

2389

1.03

0.14

1.1

1.47

1.51

g/l

0.70

221

2181

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

938

9268

1.01

0.14

3.2

3.8

52.65

59.90

u/ml

0.20

909

8963

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4546

45250

1.01

0.13

2.7

3.1

747.08

1177.83

ng/l

27.76

3717

38978

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

406

4132

0.98

0.12

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

601

0.95

0.12

1.4

85.29

223.67

nmol/24h

1.71

601

(3050794) Legionella sp Ab [Presence] in Serum

158

0.89

0.12

1.0

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

640

1.05

0.11

1.8

2.1

31.55

31.20

0.07

640

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

188

0.90

0.11

1.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.16

0.11

1.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

239

0.92

0.10

1.2

102.77

122.05

ng/l

0.15

155

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

468

4744

0.99

0.10

1.8

2.0

4.11

12.23

iu/l

1.08

150

1968

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8324

83421

1.00

0.10

6.0

6.8

11.27

11.26

umol/l

0.03

7856

79670

(3027944) Amphetamines [Presence] in Urine

570

5766

0.99

0.09

1.6

2.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

194

1900

1.02

0.09

3.4

3.6

4.41

12.46

nmol/l

1.23

184

1837

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

743

1.04

0.09

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

743

1.04

0.09

1.4

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

184

1.09

0.09

1.5

1.2

4.83

6.42

mmol/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

175

1.09

0.08

1.0

1.5

5.87

7.05

mmol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

488

4934

0.99

0.08

1.3

1.2

178.18

127.00

titre

0.26

474

(3021387) Prolactin [Units/volume] in Serum or Plasma

510

5155

0.99

0.08

1.6

1.7

268.43

301.38

mu/l

2.66

469

4677

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.77

0.08

1.0

1.1

1.39

1.30

mom

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.08

0.08

2.7

10.9

98.57

104.78

g/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

287

0.94

0.08

3.8

3.1

50.52

43.85

0.96

287

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

932

9251

1.01

0.08

2.9

4.3

24.39

24.25

mmol/l

0.87

920

9152

(3013862) HLA-DP [Type]

1.06

0.08

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

8475

84606

1.00

0.08

3.5

4.0

0.00

0.30

estimate

1.85

833

16977

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.05

0.07

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

540

1.04

0.07

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

286

0.94

0.07

7.6

6.2

7.22

8.74

0.69

286

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.06

0.07

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7343

73556

1.00

0.07

2.5

2.8

—

estimate

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

316

0.95

0.07

2.1

18.13

16.50

umol/l

0.50

316

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.03

0.07

1.1

8.12

8.23

mmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

818

1.03

0.06

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

403

1.04

0.06

1.1

—

(3027008) Opiates [Presence] in Urine

589

5844

1.01

0.06

1.6

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1823

18304

1.00

0.06

4.7

232.63

243.36

u/l

3.46

1696

17439

(3047189) Immunofixation for 24 hour Urine

740

0.97

0.06

1.9

1.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

109

1.10

0.06

1.0

0.18

0.27

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

131

1286

1.02

0.06

1.3

1.17

1.81

u/ml

0.73

743

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

517

0.97

0.06

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

530

5337

0.99

0.05

3.5

34.34

43.86

mg/l

0.96

482

4519

(44806071) Cardiolipin IgM antibody measurement

222

0.95

0.05

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

694

1.02

0.04

1.4

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

268

1.04

0.04

1.3

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

349

1.03

0.03

4.5

3.2

103.94

111.86

ng/l

0.08

146

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

256

2540

1.01

0.03

1.3

0.15

0.23

nmol/l

1.35

174

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

149

0.94

0.03

5.5

2.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1247

12436

1.00

0.03

3.0

4.0

72.20

88.63

ng/l

15.76

1089

10797

(3028717) Thiamine [Mass/volume] in Blood

239

0.96

0.02

1.1

1.2

72.39

62.16

ug/l

1.09

239

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

611

0.98

0.02

1.9

2.0

477.70

28282.24

u/ml

—

(3051611) Lipemic interference index of Serum or Plasma

154

1554

0.99

0.02

2.7

3.3

25.08

13.79

index

0.52

891

(3000764) Benzodiazepines [Presence] in Urine

583

5810

1.00

0.02

1.6

2.0

—

(3028300) Cannabinoids [Presence] in Urine

588

5860

1.00

0.02

1.6

2.0

—

(3037121) Protein [Mass/volume] in Urine

533

5311

1.00

0.02

2.8

3.4

653.62

426.38

mg/l

0.27

207

2375

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

869

1.01

0.02

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

228

0.96

0.02

1.4

1.6

108.07

113.73

ug/l

0.08

195

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

770

1.01

0.02

1.6

2.4

—

(3016879) Cocaine [Presence] in Urine

541

5425

1.00

0.01

1.7

2.1

—

(3034770) Mitochondria Ab [Titer] in Serum

486

4874

1.00

0.01

1.3

1.2

750.00

959.74

titre

—

151

(3034860) Kappa light chains.free [Mass/volume] in Serum

533

5342

1.00

0.01

3.5

36.83

60.48

mg/l

1.60

479

4530

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

154

1.04

0.00

1.1

2.27

1.67

umol/24h

0.34

154

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

516

5167

1.00

0.00

1.6

953.64

1006.48

mu/l

0.86

415

4299

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

100

994

1.01

0.00

1.5

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

119

1.01

0.00

1.1

1.2

51.04

43.32

mg/l

—

(3002619) Bacteria identified in Specimen by Culture

425

0.99

0.00

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

488

1.00

0.00

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

668

1.00

0.00

1.7

0.85

1.94

u/ml

2.18

177

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

138

1.01

0.00

1.4

1.2

103.57

111.81

ug/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

108

1.02

0.00

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

124

0.97

0.00

1.0

1.1

—

0.23

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

1.00

0.00

2.2

1.7

39.62

45.64

umol/l

0.43

130

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

490

4899

1.00

0.00

2.2

2.6

3.52

3.59

g/l

0.53

461

4689

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

181

0.99

0.00

1.1

1.5

4.12

4.69

nmol/l

0.29

173

(3028707) Methadone [Presence] in Urine by Screen method

249

2494

1.00

0.00

2.1

2.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

465

0.99

0.00

1.7

10.03

9.07

ug/l

0.75

465

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

179

1.01

0.00

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

137

1.02

0.00

1.1

1.0

—

7.13

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.99

0.00

2.2

2.3

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.98

-0.00

1.0

1.9

2.02

3.51

nmol/l

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.05

—

(40760409) HLA-A [Type] by High resolution

0.91

-0.00

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

0.91

-0.00

1.4

1.9

11.63

18.36

mmol/l

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

25.71

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40763590) HLA-DQ beta [Type]

0.92

-0.00

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.91

-0.00

1.0

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.3

—

9.50

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

12.46

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.3

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

44.57

—

(46236302) HLA-C [Type] by High resolution typing

0.91

-0.00

1.0

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.1

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.0

—

137.17

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_LYME_WIDE – Lyme disease, including avohilmo

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lyme disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Lyme disease, including avohilmo (AB1_LYME_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints